Research Article | Vol. 2, Issue 2 | Journal of Clinical Medical Research | Open Access

Screening Pilot Study of Fruit Seed Compositions by GC-MS and Their Potential Scenario Anti ACE2 and 2rh1 Receptors as a Recycling Possibility in the Coronavirus Pandemic

Asmaa Fathi Hamouda1,2*, Taymour-Lank Mohammed Farawilla3, Ibraheem Mohammed Attafi4, Ibrahim Abdu Khardali4, Mohammad Ahmad Attafi4, Magbool Essa Oraiby4, Farid Mohammad Abualsail4

1Department of Biochemistry, Faculty of Science, University of Alexandria, Alexandria, Egypt
2Assistant Professor Faculty of Applied Health Sciences, Jazan University, Saudi Arabia
3Department of Chemistry, Faculty of Science, University of Alexandria, Alexandria, Egypt
4Poison Control and Medical Forensic Chemistry Center, Ministry of Health, Jazan, Kingdom of Saudi Arabia

*Corresponding Author: Asmaa Fathi Hamouda, Alexandria University, Egypt, Assistant Professor in the Umm Al-Qura University, Saudi Arabia (2014-2016) and Assistant Professor Faculty of Applied Health Sciences, Jazan University, Saudi Arabia, Email: [email protected]

Citation: Hamouda AF, et al. Screening Pilot Study of Fruit Seed Compositions by GC-MS and Their Potential Scenario Anti ACE2 and 2rh1 Receptors as a Recycling Possibility in the Coronavirus Pandemic. J Clin Med Res. 2021;2(2) :1-65.

Copyright© 2021 by Hamouda AF, et al. All rights reserved. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received
24 Apr, 2021
Accepted
13 May, 2021
Published
20 May, 2021

Abstract

Background: Since 2019, several critical effects of the coronavirus pandemic have surfaced, including its psychological problems such as depression. The World Health Organization has approved a group of drugs and vaccines. However, the world still faces novel coronavirus mutations, requiring more ideas to investigate a drug, vaccine and phytochemical potential chemoprevention proposal. Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV)-2 co-operates directly with the Angiotensin-Converting Enzyme 2 (ACE2) to penetrate the target cells.

Aims: We aim to introduce the possibility of studying seed oil extract as an anti-depression, anti-stress, anti-epinephrine receptor (PDB: 2rh1) and as potentially binding anti-angiotensin-converting enzyme 2 (ACE2) agent.

Methods and Methodology: We analyze the constituents of the six studied seeds’ oil with Gas Chromatography-Mass Spectrometry (GC-MS) by performing an AutoDock analysis of the components’ potential ligands to both the 2rh1 and ACE2.

Results: We observe convenient binding conformations between the investigated receptors and the 44 phytoconstituents. The AutoDock outcomes of the seeds’ phytochemical GC-MS separated components reveal highly binding energy, with ACE2 higher than 2rh1.

Conclusion: The studied seed oil contains binding energy with currently studied receptors and molecular weight, which enables it to be studied in the future as a nanoparticle against viruses, vaccines and psychiatric drugs.

Keywords

Coronavirus; Depression; Seed Oil; Adrenaline; Angiotensin-Converting Enzyme 2; Autodock; Phytochemicals; Nanoparticles

Introduction

Fruit processing produces a significant quantity of wastes. The stones of fruits such as grapes (Vitis vinifera), plum (Prunus subg. Prunus: Mirabelles), apple (Malus domestic), Ajwa dates (Phoenix dactylifera L), pomegranate (Punica granatum) and avocado (Persea Americana) are the remains that are generally discarded as trash and can cause environmental problems [1,2]. Examining such underutilized wastes’ likely dietary and therapeutic potentials will also diminish the desirable environmental waste load such as river water toxicity. Seed composition depends on maturation, the environmental cultivation state and extraction protocol method that makes about 6 to 20% of the seed oil as fatty acid, vitamin and phytosterol. The seed oil compositions vary between fatty acids (oleic, palmitic, stearic, linoleic acid), vitamins (isomers tocopherol) and phytosterol (stigmasterol), according to the method of extraction [3,4].

Recently, the global coronavirus (COVID-19) pandemic has drawn scientists’ attention to the study of possible vaccines, herb and drug treatments and protection-potential medications [5,6]. The insertion of coronavirus into susceptive cells is complicated and needs some effort to assume the receptor-binding and proteolytic mechanism of virus-cell fusion. Coronaviruses (SARSr-CoV) co-operate directly with the Angiotensin-Converting Enzyme 2 (ACE2) to penetrate the target. Studies showed that ACE2 is expressed in the mouth, tongue and lower lungs on type I and II alveolar epithelial cells, promoting viral insertions in the host [6,7]. The previous mechanism helps infuse SARS-CoV-2 entry, exploits the endogenous transcriptional machinery of alveolar cells to replicate it and spreads it into the entire lung and body, where ACE2 is expressed in other organs, including the kidney, heart and gut [5-7].

ACE-1 and ACE-2 result in cleaving angiotensin peptides into angiotensin I (Ang 1) and generating angiotensin (Ang) II. Ang II has an inflammatory response that causes vasoconstriction, bronchoconstriction, increases vascular permeability and fibrosis. These previous action responses enhance Acute Respiratory Disease Syndrome (ARDS) and lung failure in patients infected with SARS-CoV-2 and that is different to the receptor number from one individual to another.

Carboxypeptidase (zinc metalloprotease) is known as ACE2, degrading Ang II to an anti-inflammatory Ang (1-7). Ang II’s conversion to Ang (1-7) by the enzyme ACE2 produces effects that oppose the Ang II-mediated action. The SARS-CoV-2 virus infects alveolar pneumocytes by binding to ACE2, leading to a decrease in Ang II conversion to ACE2-derived peptides; for instance, a reduction in Ang (1-7) and its anti-inflammatory effects prevent the effects of Ang II and led to a higher imbalance between ACE1 and ACE2. The disturbance starts a storm of an inflammatory reaction and thus, the immune response will be overcome [6,8].

Although some animal studies proposed that the application of ACEIs could provide the inhibition of and treatment for the consequences of the COVID-19 infection, different scenarios indicate that their use may increase the infection’s deleterious conditions. Therefore, more trials need to provide evidence of their effectiveness. The potential benefit-risk study of the traditional drugs and herb extracts during COVID-19 connected with other issues such as hypertension, heart failure and gut, colon and renal disease associated with diabetes should also be discussed. Further, the psychiatric consequences during the COVID-19 pandemic should be taken into consideration [5].

A previous study reported that the coronavirus (COVID-19) pandemic produced significant distress to patients with chronic illnesses, including the emotional state and perception, especially among patients with inflammatory bowel diseases [9].

Our previous study reported that dietary intake of vitamins, especially B6, B9 and B12 and herb extracts such as agarwood significantly affect mood and stress and decrease inflammation through β2 adrenoreceptor (2rh1) binging energy [10]. Moreover, the combination of the beta-adrenergic receptor block and renin-angiotensin system inhibition throughout diminished the Ang II-induced inflammatory cascade reaction and increased Ang (1-7) as well as its anti-inflammatory effects [11-13].

We hypothesize that the seed oil extract can affect both receptors and have a potential beneficial effect in decreasing the entry of viruses in the human body, decreasing storm inflammatory outcomes and improving the mood, thus decreasing stress in the COVID-19 pandemic. From this point of view, we aim to study seed oil extract as an anti-depression, anti-stress and anti-epinephrine receptor (PDB: 2rh1) ACE2.

Material and Methods

Plant Study

Plant Materials

We obtained grape (Vitis vinifera), plum (Prunus subg. Prunus: Mirabelles), apple (Malus domestic), Ajwa dates (Phoenix dactylifera L), pomegranate (Punica granatum) and avocado (Persea Americana) seeds from fruits that were collected from a local market in Saudi Arabia for this study. Here, supplementary Fig. 1 shows the experimental design. Seeds were crushed in the crushing machine and extracted with a solvent (1: 5 w/v), where the solvent compositions were hexane and ethanol (1:1). After being soaked in the solvent for 10 minutes at room temperature (28 ± 2°C), the extracts were separately concentrated with a 40-50°C rotary evaporator 14-23. The ground seeds extracted independently with (n-hexane: absolute ethanol) as (1:1) yielded 6%, 35%, 5%, 21%, 15% and 68% oil, respectively and named as GSO(Grapes (Vitis vinifera) extracts), PSO (Plum (Prunus subg. Prunus: Mirabelles) extracts), ASO (Apple (Malus domestic) extracts), AWSO (Ajwa dates (Phoenix dactylifera L) extracts), PGSO (Pomegranate (Punica granatum) extracts), AVSO (Avocado (Persea Americana) extracts).

Figure 1: Experimental design. *Abbreviations: GSO: Grapes (Vitis vinifera) extracts; PSO: Plum (Prunus subg. Prunus: Mirabelles) extracts; ASO: Apple (Malus domestic) extracts; AWSO: Ajwa dates (Phoenix dactylifera L) extracts; PGSO: Pomegranate (Punica granatum) extracts; AVSO: Avocado (Persea Americana) extracts; GC-MS: Gas Chromatography-Mass Spectrometry; 2RH1: Epinephrine receptor; ACE2: Angiotensin-converting enzyme 2.

Gas Chromatography-Mass Spectrometry Analysis

We followed our previous method for the Gas Chromatography-Mass Spectrometry (GC-MS) analysis to separate the chemical constituents of the extract using a gas chromatography system (G3440B, Agilent Technologies, USA) [24].

The seeds extracts were re-dissolved in ethanol and filtered using a nylon 0.45 μm pore size membrane filter separately. The GC-MS analysis was performed using a general screening method [24]. The separation column was from Thermo Fisher Scientific (TR-5MS) and had the following properties: 30 m length, Internal Diameter (ID) 0.25 mm and film thickness 0.25 µm. The carrier gas was helium and the flow rate was 1 ml/min. A total of 2 µl of each sample was injected into splitless mode at an injection port with a temperature of 260ºC. The GC thermal program started at 80ºC and was conducted for 1.5 min. Next, the thermal program increased at the first ramp to 210ºC at a rate of 30ºC/min and then the rate was slowed to 20ºC/min to reach the final temperature of 320ºC; this temperature was held for 11 min. The ion source in MS was Electron Ionization (EI) and the analysis was conducted in a scanning mode with an electron energy of 70 eV. The ion source and transfer line temperatures were adjusted to 230ºC. The composites of the plant extract were identified by computer explorations in the commercial libraries of Wiley and NIST (National Institute of Standards and Technology).

We then searched the Wiley and NIST mass spectral libraries to identify the chemical components of the seeds extract [24]. Furthermore, we screened the unique seed extracts separately for components with AutoDock to determine their potential as ligands of the anti-epinephrine receptor (PDB: 2rh1) and ACE2 to provide more convincing proof of the therapeutic opportunities provided by GSO, PSO, ASO, AWSO, PGSO and AVSO [25,26].

Autodock Analysis

Preparation of the modelled epinephrine receptor (PDB: 2rh1), Angiotensin-Converting Enzyme 2 (ACE2) and specific GSO, PSO, ASO, AWSO, PGSO and AVSO components for docking

The AutoDock Vina 4.2 software includes procedures for optimizing proteins and ligands, such as allowing atomic charges to make proteins more polar [26-29]. Proteins and ligands were adjusted through the charge and rotatable bond authorization, consideration of the energy contribution of desolvation through the binding of a ligand to the protein and previous naming of grid maps of the protein surface for synergy ligands by the auto grid. These tools increase the speed and accuracy of docking with a unique scoring capacity, optimize effectively and perform the multithreading of the molecular docking [26-29].

Result and Discussion

GC-MS Analysis Outcomes

The GC-MS analysis identified the chemical composition of GSO, PSO, ASO, AWSO, PGSO and AVSO extracts. The specific components that are unique to the extract are presented in Table 1-6, which include the chemical name, molecular weight, retention time and area percentage. Besides, Table 7 illustrates the results of the GC-MS chromatogram of the selected compounds in the studied seeds, namely, GSO, PSO, ASO, AWSO, PGSO and AVSO.

Area

Name

Formula

Mass (DB)

Base Peak

RT

Score (Lib)

CAS

Library

1153381

9-Octadecenamide, (Z)

C18H35NO

281.3

59

14.014

96.01

301-02-0

NIST11.L

553719

9-Octadecenamide, (Z)

C18H35NO

281.3

59

14.068

95.12

301-02-0

NIST11.L

312347

9-Octadecenamide, (Z)

C18H35NO

281.3

59

14.132

80.8

301-02-0

NIST11.L

253901

Stigmastan-3,5-diene

C29H48

396.4

396.4

19.823

82.64

1000214-16-4

NIST11.L

196415

9,12-Octadecadienoic acid (Z,Z)-, methyl ester

C19H34O2

294.3

81.1

12.335

88.67

112-63-0

NIST11.L

163338

Oleamide

C18H35NO

281

59

15.137

69.43

301-02-0

SWGDRUG.L

159068

9-Octadecenoic acid (Z)-, methyl ester

C19H36O2

296.3

55

12.367

79.86

112-62-9

NIST11.L

151791

Stigmastan-3,5-diene

C29H48

396.4

145.1

18.24

70.76

1000214-16-4

NIST11.L

122124

Hexadecanamide

C16H33NO

255.3

59

12.944

86.69

629-54-9

NIST11.L

117526

Phosphoric acid, trimethyl ester

C3H9O4P

140

110

3.274

90.14

512-56-1

NIST11.L

85055

Dodecyl acrylate

C15H28O2

240.2

55

9.575

89.7

2156-97-0

NIST11.L

61663

Pentanoic acid, 5-hydroxy-, 2,4-di-t-butylphenyl esters

C19H30O3

306.2

191.2

8.28

61.18

166273-38-7

NIST11.L

59729

Methyl stearate

C19H38O2

298.3

74

12.501

73.68

112-61-8

NIST11.L

46671

1-Pentadecyne

C15H28

208.2

55

12.736

75.63

765-13-9

NIST11.L

45722

Hexadecanoic acid, methyl ester

C17H34O2

270.3

74

11.217

88.84

112-39-0

NIST11.L

32926

11,13-Dimethyl-12-tetradecen-1-ol acetate

C18H34O2

282.3

207

14.656

65.15

1000130-81-0

NIST11.L

32557

4-Methyl-2,4-bis(4’-trimethylsilyloxyphenyl)pentene-1

C24H36O2Si2

412.2

207

21.984

60.24

1000283-56-8

NIST11.L

25237

1,3-Benzenediol, o-(4-methylbenzoyl)-o’-(2-methoxybenzoyl)-

C22H18O5

362.1

135.1

5.67

80.17

1000330-77-7

NIST11.L

20103

2-Bromotetradecane

C14H29Br

276.1

71.1

9.543

71.68

74036-95-6

NIST11.L

12553

Cyclotrisiloxane, hexamethyl-

C6H18O3Si3

222.1

207

17.443

62.3

541-05-9

NIST11.L

11645

Isooctyl 3-mercaptopropionate

C11H22O2S

218.1

57

11.907

66.69

30374-01-7

NIST11.L

Table 1: Results of the GC-MS analysis of the Grape Seed Extract (GSO).

Area

Name

Formula

Score

Mass (DB)

Base Peak

RT

CAS

Library

1754219

9-Octadecenamide, (Z)

C18H35NO

95.39

281.3

59

14.014

301-02-0

NIST11.L

837978

9-Octadecenamide, (Z)

C18H35NO

94.8

281.3

59

14.073

301-02-0

NIST11.L

412230

9,12-Octadecadienoic acid (Z,Z)

C18H32O2

74.12

280.2

55

12.709

60-33-3

NIST11.L

354051

Octadecanamide

C18H37NO

82.57

283.3

59

14.132

124-26-5

NIST11.L

336429

9-Octadecenoic acid, methyl ester, (E)

C19H36O2

91.3

296.3

55

12.367

1937-62-8

NIST11.L

335665

9-Octadecenamide, (Z)

C18H35NO

76.36

281.3

59

15.137

301-02-0

NIST11.L

295258

Benzamide, N-(1,3-dihydro-2-oxo-4-isobenzofuryl)

C15H11NO3

67.17

253.1

105

3.563

1000270-36-9

NIST11.L

248784

Squalene

C30H50

88.57

410.4

69.1

16.539

111-02-4

NIST11.L

201429

Hexadecanamide

C16H33NO

88.56

255.3

59

12.944

629-54-9

NIST11.L

200337

9,12-Octadecadienoic acid (Z,Z)-, methyl ester

C19H34O2

90.13

294.3

81.1

12.335

112-63-0

NIST11.L

196440

Dodecyl acrylate

C15H28O2

89.05

240.2

55

9.575

2156-97-0

NIST11.L

133468

Stigmastan-3,5-diene

C29H48

70.87

396.4

396.4

19.817

1000214-16-4

NIST11.L

103286

cis-11-Hexadecenal

C16H30O

72.19

238.2

55

14.271

53939-28-9

NIST11.L

99402

Pentanoic acid, 5-hydroxy-, 2,4-di-t-butylphenyl esters

C19H30O3

64.7

306.2

191.2

8.275

166273-38-7

NIST11.L

90774

Oleamide

C18H35NO

68.81

281

59

16.474

301-02-0

SWGDRUG.L

80042

Stigmastan-3,5-diene

C29H48

61.13

396.4

207

18.245

1000214-16-4

NIST11.L

71117

Hexadecane

C16H34

60.94

226.3

71.1

7.874

544-76-3

NIST11.L

70968

Propanoic acid, 3-mercapto-, dodecyl ester

C15H30O2S

81.54

274.2

57.1

11.901

6380-71-8

NIST11.L

62331

Methyl stearate

C19H38O2

80.22

298.3

74

12.5

112-61-8

NIST11.L

59517

1,3-Benzenediol, o-(4-methylbenzoyl)-o’-(2-methoxybenzoyl)-

C22H18O5

80.78

362.1

135.1

5.676

1000330-77-7

NIST11.L

56219

Hexadecanoic acid, methyl ester

C17H34O2

88.83

270.3

74

11.217

112-39-0

NIST11.L

53892

1,2-15,16-Diepoxyhexadecane

C16H30O2

64.14

254.2

67

14.528

1000192-65-0

NIST11.L

45286

Dodecane, 1-iodo-

C12H25I

73.33

296.1

71.1

9.543

4292-19-7

NIST11.L

41330

Oxalic acid, cyclobutyl octadecyl ester

C24H44O4

64.72

396.3

55

13.554

1000309-70-8

NIST11.L

31933

(R)-(-)-14-Methyl-8-hexadecyn-1-ol

C17H32O

73.75

252.2

67

12.912

64566-18-3

NIST11.L

28347

11,13-Dimethyl-12-tetradecen-1-ol acetate

C18H34O2

66.06

282.3

207

14.656

1000130-81-0

NIST11.L

21037

Cyclotrisiloxane, hexamethyl-

C6H18O3Si3

61.01

222.1

207

29.14

541-05-9

NIST11.L

Table 2: Results of the GC-MS analysis of the Plum Seed Extract (PSO).

Area

Name

Formula

Score

Mass (DB)

Base Peak

RT

CAS

Library

6889234

9-Octadecenamide, (Z)

C18H35NO

94.13

281.3

59

14.03

301-02-0

NIST11.L

2945751

9-Octadecenamide, (Z)

C18H35NO

93.78

281.3

59

14.089

301-02-0

NIST11.L

1033287

cis-Vaccenic acid

C18H34O2

88.05

282.3

55.1

12.688

506-17-2

NIST11.L

1008732

9-Octadecenamide, (Z)

C18H35NO

86.69

281.3

59

14.142

301-02-0

NIST11.L

954396

cis-11-Eicosenamide

C20H39NO

88.97

309.3

59

15.143

10436-08-5

NIST11.L

610895

Hexadecanamide

C16H33NO

90.15

255.3

59

12.95

629-54-9

NIST11.L

593475

cis-11-Eicosenamide

C20H39NO

89.3

309.3

59

15.175

10436-08-5

NIST11.L

388532

Benzoic acid

C7H6O2

90.25

122

105

5.456

65-85-0

NIST11.L

323156

9-Octadecenoic acid (Z), methyl ester

C19H36O2

94.1

296.3

55

12.367

112-62-9

NIST11.L

267970

13-Docosenamide, (Z)

C22H43NO

83.16

337.3

59

16.48

112-84-5

NIST11.L

240133

Squalene

C30H50

83.22

410.4

69.1

16.539

111-02-4

NIST11.L

220504

9,12-Octadecadienoic acid (Z,Z), methyl ester

C19H34O2

85.99

294.3

55.1

12.34

112-63-0

NIST11.L

166826

2-pyrrolidinovalerophenone

C15H21NO

61.27

231.2

126

4.483

1000379-01-6

NIST11.L

160890

9,12-Octadecadienoic acid (Z,Z)

C18H32O2

80.2

280.2

55

12.843

60-33-3

NIST11.L

156823

2-Furancarboxaldehyde, 5-methyl-

C6H6O2

68.01

110

110

3.568

620-02-0

NIST11.L

149932

2,5,5-Trimethyl-3-hexyn-2-ol

C9H16O

62.81

140.1

125.1

4.173

1522-16-3

NIST11.L

149396

dl-.alpha.-Tocopherol

C29H50O2

84.28

430.4

165.1

20.026

10191-41-0

NIST11.L

148913

13-Tetradecenal

C14H26O

69.47

210.2

55

14.271

85896-31-7

NIST11.L

145902

Dodecyl acrylate

C15H28O2

77.77

240.2

55

9.575

2156-97-0

NIST11.L

134293

9-Octadecenamide, (Z)

C18H35NO

71.12

281.3

59

15.26

301-02-0

NIST11.L

115541

Phosphoric acid, trimethyl ester

C3H9O4P

76.47

140

110

3.269

512-56-1

NIST11.L

114363

9-Octadecenoic acid (Z), methyl ester

C19H36O2

87.2

296.3

55

12.393

112-62-9

NIST11.L

104507

9,12-Octadecadienoic acid (Z,Z), phenylmethyl ester

C25H38O2

68.52

370.3

91.1

16.314

47557-83-5

NIST11.L

99081

4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl-

C6H8O4

78.5

144

43

5.109

28564-83-2

NIST11.L

89982

7-Decen-1-ol acetate

C12H22O2

65.77

198.2

198.1

10.58

1000130-98-7

NIST11.L

73813

13-Octadecenal, (Z)

C18H34O

74.15

266.3

55

13.554

58594-45-9

NIST11.L

Table 3: Results of the GC-MS analysis of the Apple Seed Extract (ASO).

Area

Name

Formula

Score

Mass (DB)

Base Peak

RT

CAS

Library

11938939

5-Hydroxymethylfurfural

C6H6O3

93.69

126

97

5.981

67-47-0

NIST11.L

7187956

9-Octadecenamide, (Z)

C18H35NO

93.41

281.3

59

14.036

301-02-0

NIST11.L

2795712

Oleic Acid

C18H34O2

89.41

282.3

55.1

12.688

112-80-1

NIST11.L

2786153

9-Octadecenamide, (Z)

C18H35NO

92.81

281.3

59

14.089

301-02-0

NIST11.L

1941282

5-Methyl-2-pyrazinylmethanol

C6H8N2O

71.12

124.1

95

4.526

61892-95-3

NIST11.L

1755089

4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl-

C6H8O4

85.74

144

144.1

5.13

28564-83-2

NIST11.L

1340413

9-Octadecenamide, (Z)

C18H35NO

85.7

281.3

59

14.143

301-02-0

NIST11.L

1137031

cis-11-Eicosenamide

C20H39NO

88.05

309.3

59

15.143

10436-08-5

NIST11.L

1010531

Hexadecanamide

C16H33NO

89.11

255.3

59

12.955

629-54-9

NIST11.L

913214

.alpha.-D-Glucopyranoside, O-.alpha.-D-glucopyranosyl-(1.fwdarw.3)-.beta.-D-fructofuranosyl

C18H32O16

68.86

504.2

60

8.575

597-12-6

NIST11.L

523476

Dodecanoic acid

C12H24O2

62.4

200.2

101

7.232

143-07-7

NIST11.L

519466

Palmitic Acid

C16H32O2

82.97

256

73

11.554

57-10-3

SWGDRUG.L

464464

2,4-Dimethyl-3-pentanol acetate

C9H18O2

68.65

158.1

115.1

4.938

84612-74-8

NIST11.L

454918

.alpha.-D-Glucopyranoside, O-.alpha.-D-glucopyranosyl-(1.fwdarw.3)-.beta.-D-fructofuranosyl

C18H32O16

62.2

504.2

97

6.751

597-12-6

NIST11.L

445645

d-Glycero-l-gluco-heptose

C7H14O7

69.94

210.1

73

9.457

1000130-14-6

NIST11.L

422390

7-Methyl-Z-tetradecen-1-ol acetate

C17H32O2

60.7

268.2

71

7.516

1000130-99-6

NIST11.L

384795

Dodecanoic acid

C12H24O2

62.21

200.2

97

7.088

143-07-7

NIST11.L

343639

.alpha.-D-Glucopyranoside, O-.alpha.-D-glucopyranosyl-(1.fwdarw.3)-.beta.-D-fructofuranosyl

C18H32O16

69.04

504.2

43

4.226

597-12-6

NIST11.L

338707

9-Octadecenoic acid (Z), methyl ester

C19H36O2

93.39

296.3

55.1

12.367

112-62-9

NIST11.L

306881

Levoglucosenone

C6H6O3

74.73

126

98

4.836

37112-31-5

NIST11.L

275232

13-Docosenamide, (Z)

C22H43NO

82.89

337.3

59

16.48

112-84-5

NIST11.L

261583

Squalene

C30H50

74.99

410.4

69.1

16.539

111-02-4

NIST11.L

243810

Cyclopropanecarboxylic acid, 3-formyl-2,2-dimethyl-, ethyl ester

C9H14O3

68.54

170.1

141.1

6.371

66692-75-9

NIST11.L

229093

7,10-Octadecadienoic acid, methyl ester

C19H34O2

86.45

294.3

55.1

12.34

56554-24-6

NIST11.L

194471

Stigmastan-3,5-diene

C29H48

79.33

396.4

396.4

19.828

1000214-16-4

NIST11.L

180044

1H-Inden-1-ol, 2,3-dihydro-

C9H10O

66.21

134.1

133.1

5.815

########

NIST11.L

166539

Phenol, 2,6-bis(1,1-dimethylethyl)-

C14H22O

64.8

206.2

191.2

8.27

128-39-2

NIST11.L

144137

Dodecanoic acid, 3-hydroxy-

C12H24O3

75.86

216.2

73

9.58

1883-13-2

NIST11.L

135632

Stigmastan-3,5-diene

C29H48

71.22

396.4

145.1

18.245

1000214-16-4

NIST11.L

129752

Chloro(2-methyloxiran-2-yl)acetic acid, t-butyl ester

C9H15ClO3

63.1

206.1

57

5.676

1000195-30-2

NIST11.L

129419

9-Octadecenamide, (Z)

C18H35NO

73.1

281.3

59

15.26

301-02-0

NIST11.L

124757

7-Methyl-Z-tetradecen-1-ol acetate

C17H32O2

67.8

268.2

109

11.907

1000130-99-6

NIST11.L

Table 4: Results of the GC-MS analysis of the AJWA DATE SEED EXTRACT (AWSO).

Area

Name

Formula

Score

Mass (DB)

Base Peak

RT

CAS

Library

7881254

9-Octadecenamide, (Z)

C18H35NO

94.13

281.3

59

14.035

301-02-0

NIST11.L

3678871

9-Octadecenamide, (Z)

C18H35NO

93.57

281.3

59

14.094

301-02-0

NIST11.L

2484499

Squalene

C30H50

94.66

410.4

69.1

16.544

111-02-4

NIST11.L

1890724

.gamma.-Tocopherol

C28H48O2

94.32

416.4

416.4

19.052

7616-22-0

NIST11.L

1614995

Octadecanamide

C18H37NO

87.45

283.3

59

14.142

124-26-5

NIST11.L

1306538

cis-11-Eicosenamide

C20H39NO

86.97

309.3

59

15.143

10436-08-5

NIST11.L

851742

cis-11-Eicosenamide

C20H39NO

86.97

309.3

59

15.18

10436-08-5

NIST11.L

809801

Hexadecanamide

C16H33NO

91.31

255.3

59

12.95

629-54-9

NIST11.L

731639

13-Docosenamide, (Z)

C22H43NO

93.29

337.3

59

16.48

112-84-5

NIST11.L

670773

5-Hydroxymethylfurfural

C6H6O3

78.42

126

97

5.815

67-47-0

NIST11.L

329977

9,12-Octadecadienoic acid (Z,Z)

C18H32O2

83.51

280.2

55

12.688

60-33-3

NIST11.L

259024

Stigmastan-3,5-diene

C29H48

82.99

396.4

396.4

19.823

1000214-16-4

NIST11.L

236786

9-Octadecenamide, (Z)

C18H35NO

72.37

281.3

59

15.26

301-02-0

NIST11.L

183380

9-Octadecenoic acid, methyl ester, (E)

C19H36O2

90.67

296.3

55.1

12.367

1937-62-8

NIST11.L

177775

Stigmastan-3,5-diene

C29H48

71.73

396.4

145.1

18.245

1000214-16-4

NIST11.L

155592

Dodecyl acrylate

C15H28O2

86.06

240.2

55

9.58

2156-97-0

NIST11.L

136483

7-Hexadecenal, (Z)

C16H30O

74.64

238.2

55

13.554

56797-40-1

NIST11.L

132310

Oleamide

C18H35NO

76.78

281

59

14.271

301-02-0

SWGDRUG.L

127624

Pentanoic acid, 5-hydroxy-, 2,4-di-t-butylphenyl esters

C19H30O3

65.87

306.2

191.2

8.27

166273-38-7

NIST11.L

122878

Oleanitrile

C18H33N

88.92

263.3

55

12.334

1000308-88-1

NIST11.L

121687

Octadecanoic acid

C18H36O2

77.44

284.3

55

12.843

57-11-4

NIST11.L

98579

n-Hexadecanoic acid

C16H32O2

75.86

256.2

73

11.554

57-10-3

NIST11.L

88320

Erucic Acid

C22H42O2

73.59

338

55.1

14.656

112-86-7

SWGDRUG.L

Table 5: Results of the GC-MS analysis of the Pomegranate Seed Extract (PGSO).

Area

Name

Formula

Score

Mass (DB)

Base Peak

RT

CAS

Library

2897082

Cyclodecacyclododecene, 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18-octadecahydro-

C20H36

69.15

276.3

94.1

12.297

14113-80-5

NIST11.L

2811595

9-Octadecenamide, (Z)

C18H35NO

93.38

281.3

59

14.02

301-02-0

NIST11.L

2745454

2H-Pyran, 2-(7-heptadecynyloxy)tetrahydro-

C22H40O2

80.95

336.3

81.1

12.891

56599-50-9

NIST11.L

2319924

E,Z-3,13-Octadecadien-1-ol acetate

C20H36O2

80.52

308.3

81.1

10.372

1000130-91-2

NIST11.L

1680890

1-Hexadecyn-3-ol, 3,7,11,15-tetramethyl-

C20H38O

73

294.3

69

13.11

29171-23-1

NIST11.L

1357304

Androstan-17-one, 3-ethyl-3-hydroxy-, (5.alpha.)-

C21H34O2

80.78

318.3

94.1

13.351

57344-99-7

NIST11.L

1283909

Z,E-2,13-Octadecadien-1-ol

C18H34O

76.45

266.3

85

13.581

1000131-10-3

NIST11.L

1250645

Cyclodecacyclododecene, 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18-octadecahydro-

C20H36

81.34

276.3

94

11.752

14113-80-5

NIST11.L

1092568

Chrysene, octadecahydro-

C18H30

75.03

246.2

94.1

10.923

2090-14-4

NIST11.L

1058031

9-Octadecenamide, (Z)

C18H35NO

92.94

281.3

59

14.078

301-02-0

NIST11.L

1009366

9-Octadecenamide, (Z)

C18H35NO

83.68

281.3

59

14.137

301-02-0

NIST11.L

849953

cis-11-Eicosenamide

C20H39NO

83.93

309.3

59

15.143

10436-08-5

NIST11.L

782505

Bicyclo[10.8.0]eicosane, (E)

C20H38

75.55

278.3

81

11.789

1000155-85-0

NIST11.L

674421

Hexadecanamide

C16H33NO

68.87

255.3

69

12.95

629-54-9

NIST11.L

592928

dl-.alpha.-Tocopherol

C29H50O2

94.47

430.4

430.4

20.026

10191-41-0

NIST11.L

559398

Bicyclo[10.6.0]octadeca-1(12),15-diene

C18H30

82.51

246.2

94.1

10.334

1000155-85-1

NIST11.L

558452

Formic acid, 3,7,11-trimethyl-1,6,10-dodecatrien-3-yl ester

C16H26O2

74.54

250.2

121

13.779

1000132-11-0

NIST11.L

540335

cis-10-Nonadecenoic acid

C19H36O2

76.96

296.3

85.1

14.699

73033-09-7

NIST11.L

517071

Bicyclo[10.6.0]octadeca-1(12),15-diene

C18H30

79.35

246.2

81.1

10.596

1000155-85-1

NIST11.L

504483

Farnesol isomer a

C15H26O

80.22

222.2

69

13.297

1000108-92-4

NIST11.L

486502

3-Chloropropionic acid, heptadecyl ester

C20H39ClO2

86.52

346.3

55

9.58

1000283-05-1

NIST11.L

445890

Z,Z-4,6-Nonadecadien-1-ol acetate

C21H38O2

74.05

322.3

95.1

13.971

1000131-08-4

NIST11.L

438822

cis-9-Hexadecenoic acid, trimethylsilyl ester

C19H38O2Si

66.59

326.3

117

13.709

1000333-19-8

NIST11.L

422108

2H-Pyran, 2-(7-heptadecynyloxy)tetrahydro-

C22H40O2

82.98

336.3

85.1

15.715

56599-50-9

NIST11.L

372034

9,12-Octadecadienoic acid (Z,Z)

C18H32O2

81.92

280.2

55

12.709

60-33-3

NIST11.L

345493

2H-Pyran, 2-(7-dodecynyloxy)tetrahydro-

C17H30O2

74.06

266.2

85

14.586

16695-32-2

NIST11.L

319949

12-Methyl-E,E-2,13-octadecadien-1-ol

C19H36O

77.79

280.3

69

14.276

1000130-90-4

NIST11.L

308267

1-Heptatriacotanol

C37H76O

81.96

536.6

95.1

16.148

105794-58-9

NIST11.L

267929

Oleic Acid

C18H34O2

70.63

282.3

55

11.538

112-80-1

NIST11.L

251122

Stigmastan-3,5-diene

C29H48

83.63

396.4

396.4

19.828

1000214-16-4

NIST11.L

227979

Cyclodecacyclotetradecene, 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20-eicosahydro-

C22H40

76.61

304.3

94

13.517

14113-62-3

NIST11.L

225643

9-Cycloheptadecen-1-one, (Z)

C17H30O

74.34

250.2

81.1

10.409

542-46-1

NIST11.L

224112

12-Methyl-E,E-2,13-octadecadien-1-ol

C19H36O

80

280.3

85

14.544

1000130-90-4

NIST11.L

220290

9,12,15-Octadecatrienoic acid, 2-(acetyloxy)-1-[(acetyloxy)methyl]ethyl ester, (Z,Z,Z)

C25H40O6

67.89

436.3

117

13.667

55320-01-9

NIST11.L

217000

Phenol, 2-undecyl-

C17H28O

76.37

248.2

94.1

10.955

20056-71-7

NIST11.L

214629

E,E,Z-1,3,12-Nonadecatriene-5,14-diol

C19H34O2

73.79

294.3

111.1

14.94

1000131-11-4

NIST11.L

201901

cis-9-Hexadecenal

C16H30O

80.37

238.2

97.1

11.447

56219-04-6

NIST11.L

197393

13-Docosenamide, (Z)

C22H43NO

77.49

337.3

59

16.48

112-84-5

NIST11.L

196079

Caryophyllene oxide

C15H24O

75.62

220.2

133.1

12.565

1139-30-6

NIST11.L

174210

2-Acetoxy-1,1,10-trimethyl-6,9-epidioxydecalin

C15H24O4

76.87

268.2

85

13.469

108511-84-8

NIST11.L

173866

9-Octadecenoic acid (Z)-, methyl ester

C19H36O2

84.25

296.3

55

12.367

112-62-9

NIST11.L

158247

Sclaral (sclareolide lactol)

C16H28O2

70.48

252.2

237.2

14.886

52811-62-8

NIST11.L

148648

2-Isoamylpyrazine

C9H14N2

68.98

150.1

94.1

12.089

40790-22-5

NIST11.L

144711

.gamma.-Tocopherol

C28H48O2

66.81

416.4

151.1

19.047

7616-22-0

NIST11.L

130975

p-Menth-8-en-3-ol, acetate

C12H20O2

71.42

196.1

121

12.522

89-49-6

NIST11.L

127798

Farnesol isomer a

C15H26O

74.05

222.2

69

13.014

1000108-92-4

NIST11.L

121571

Hexadecanoic acid, methyl ester

C17H34O2

60.81

270.3

74

11.222

112-39-0

NIST11.L

119991

Sclaral (sclareolide lactol)

C16H28O2

74.41

252.2

237.2

14.635

52811-62-8

NIST11.L

118782

11,13-Dimethyl-12-tetradecen-1-ol acetate

C18H34O2

70.73

282.3

69.1

16.539

1000130-81-0

NIST11.L

117278

Oleic Acid

C18H34O2

71.31

282.3

55

11.639

112-80-1

NIST11.L

114475

2-Acetoxy-1,1,10-trimethyl-6,9-epidioxydecalin

C15H24O4

75.39

268.2

85

15.608

108511-84-8

NIST11.L

104445

2-Acetoxy-1,1,10-trimethyl-6,9-epidioxydecalin

C15H24O4

72.68

268.2

59

15.26

108511-84-8

NIST11.L

102635

12-Methyl-E,E-2,13-octadecadien-1-ol

C19H36O

73.38

280.3

43

14.779

1000130-90-4

NIST11.L

97105

12-Methyl-E,E-2,13-octadecadien-1-ol

C19H36O

74.25

280.3

85.1

15.528

1000130-90-4

NIST11.L

95395

11,13-Dimethyl-12-tetradecen-1-ol acetate

C18H34O2

69.81

282.3

57.1

16.758

1000130-81-0

NIST11.L

90205

Formic acid, 3,7,11-trimethyl-1,6,10-dodecatrien-3-yl ester

C16H26O2

64.55

250.2

117

13.886

1000132-11-0

NIST11.L

83029

9,12-Octadecadienoic acid (Z,Z), methyl ester

C19H34O2

82.86

294.3

94

12.335

112-63-0

NIST11.L

81266

Stigmastan-3,5-diene

C29H48

62.42

396.4

207

19.352

1000214-16-4

NIST11.L

80710

7-Methyl-Z-tetradecen-1-ol acetate

C17H32O2

73.25

268.2

117

13.843

1000130-99-6

NIST11.L

79895

Cyclohexane, 1,5-diethenyl-2,3-dimethyl-, (1.alpha.,2.beta.,3.beta.,5.beta.)-

C12H20

66.11

164.2

94

10.693

68779-12-4

NIST11.L

79553

Caryophyllene oxide

C15H24O

80.12

220.2

95

13.174

1139-30-6

NIST11.L

75917

Heptacosane

C27H56

67.85

380.4

57

17.475

593-49-7

NIST11.L

68591

Phenol, 2,5-bis(1,1-dimethylethyl)-

C14H22O

60.78

206.2

191.2

8.27

5875-45-6

NIST11.L

67261

Propanoic acid, 3-mercapto-, dodecyl ester

C15H30O2S

78.73

274.2

57.1

11.901

6380-71-8

NIST11.L

67173

2-Acetoxy-1,1,10-trimethyl-6,9-epidioxydecalin

C15H24O4

77.39

268.2

85.1

13.42

108511-84-8

NIST11.L

63628

2-Bromotetradecane

C14H29Br

72.05

276.1

71.1

9.543

74036-95-6

NIST11.L

62123

1,2-15,16-Diepoxyhexadecane

C16H30O2

77.92

254.2

69.1

13.046

1000192-65-0

NIST11.L

61775

1,2-15,16-Diepoxyhexadecane

C16H30O2

74.2

254.2

97.1

9.997

1000192-65-0

NIST11.L

60013

12-Methyl-E,E-2,13-octadecadien-1-ol

C19H36O

81.12

280.3

95

14.335

1000130-90-4

NIST11.L

59523

Heptacosane

C27H56

66.66

380.4

57

17.234

593-49-7

NIST11.L

57603

Phosphoric acid, trimethyl ester

C3H9O4P

87.9

140

110

3.279

512-56-1

NIST11.L

56870

7-Hexadecenal, (Z)

C16H30O

74.19

238.2

57.1

12.217

56797-40-1

NIST11.L

50564

Heptacosane

C27H56

75.64

380.4

71.1

15.929

593-49-7

NIST11.L

49635

2-methyltetracosane

C25H52

79.82

352.4

43

11.04

1000376-72-6

NIST11.L

44135

2-methyltetracosane

C25H52

76.32

352.4

71.1

11.083

1000376-72-6

NIST11.L

42262

3H-3,10a-Methano-1,2-benzodioxocin-3-ol, octahydro-7,7-dimethyl-, (3.alpha.,6a.beta.,10a.beta.)-

C13H22O3

66.26

226.2

81

10.447

95906-83-5

NIST11.L

41762

(2,2,6-Trimethyl-bicyclo[4.1.0]hept-1-yl)-methanol

C11H20O

67.8

168.2

94

10.73

78996-11-9

NIST11.L

41510

11,13-Dimethyl-12-tetradecen-1-ol acetate

C18H34O2

63.75

282.3

57

16.341

1000130-81-0

NIST11.L

41096

1,2-15,16-Diepoxyhexadecane

C16H30O2

77.5

254.2

69

13.207

1000192-65-0

NIST11.L

39859

Tricyclo[4.3.0.0(7,9)]nonane, 2,2,5,5,8,8-hexamethyl-, (1.alpha.,6.beta.,7.alpha.,9.alpha.)-

C15H26

64.69

206.2

81

10.27

54832-82-5

NIST11.L

33905

11,13-Dimethyl-12-tetradecen-1-ol acetate

C18H34O2

76.72

282.3

69.1

15.383

1000130-81-0

NIST11.L

31812

2-Bromotetradecane

C14H29Br

64.58

276.1

71.1

9.874

74036-95-6

NIST11.L

29097

11,13-Dimethyl-12-tetradecen-1-ol acetate

C18H34O2

71.69

282.3

57

18.662

1000130-81-0

NIST11.L

*Notes for Tables 1-7: RT: Retention times (minutes); PA: peak area (%).

GC–MS analysis was carried for the Hexane: ethanoic (1:1) extracts applying Agilent Technologies (G3440B, USA).

The components of plant extract were characterized by computer simulations in commercial libraries of Wiley and NIST (National Institute of Standards and Technology).

The CAS number is a database index to identifying a given chemical

GSO: Grape (Vitis vinifera) extracts; PSO: Plum (Prunus subg. Prunus: Mirabelles) extracts; ASO: Apple (Malus domestic) extracts; AWSO: Ajwa dates (Phoenix dactylifera L) extracts; PGSO: Pomegranate( Punica granatum) extracts; AVSO: Avocado (Persea Americana) extracts

Table 6: Results of the GC-MS analysis of the Avocado Seed Extract (AVSO).

Compounds

Chemical (PubChem CID:)

GC MS SPECTRA(Chromatogram)

9-Octadecenamide, (Z)-

Or Oleamide

Present in all(GSO, PSO, ASO, AWSO, PGSO, AVSO)

Compound CID: 5283387

MF:                        C18H35NO

MW:                      281.5g/mol

InChIKey:            FATBGEAMYMYZAF-KTKRTIGZSA-N

IUPAC Name:     (Z)-octadec-9-enamide

Create Date:        2005-03-27

 

Stigmastan-3,5-diene

Present in (GSO, PSO, AWSO, PGSO, AVSO)

Compound CID: 525918

MF:                        C29H48

MW:                      396.7g/mol

InChIKey:            ICCTZARHLGPHMT-UHFFFAOYSA-N

IUPAC Name:     17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-                             2,7,8,9,11,12,14,15,16,17-decahydro-1H-                                                cyclopenta[a]phenanthrene

Create Date:        2005-03-27

 

Hexadecanamide

Present in all(GSO, PSO, ASO, AWSO, PGSO, AVSO

Compound CID:  69421

MF:                        C16H33NO

MW:                      255.44g/mol

InChIKey:            HSEMFIZWXHQJAE-UHFFFAOYSA-N

IUPAC Name:     hexadecanamide

Create Date:        2005-03-26

 

Pentanoic acid, 5-hydroxy-, 2,4-di-t-butylphenyl esters

Present in GSO, PSO , PGSO

Compound CID: 605777

MF:                        C19H30O3

MW:                      306.4g/mol

InChIKey:            ZUILXYOZKNAZSJ-UHFFFAOYSA-N

IUPAC Name:     (2,4-ditert-butylphenyl) 5-hydroxypentanoate

Create Date:        2005-03-27

 

Methyl stearate

GSO, PSO ONLY

Compound CID: 8201

MF:                        C19H38O2

MW:                      298.5g/mol

InChIKey:            HPEUJPJOZXNMSJ-UHFFFAOYSA-N

IUPAC Name:     methyl octadecanoate

Create Date:        2005-03-26

 

4-Methyl-2,4-bis(4′-trimethylsilyloxyphenyl)pentene-1

Present in GSO, PSO, ONLY

Compound CID:  610040

MF:                        C24H36O2Si2

MW:                      412.7g/mol

InChIKey:            YCRIXHKHAODKFH-UHFFFAOYSA-N

IUPAC Name:     trimethyl-[4-[2-methyl-4-(4-                                                                trimethylsilyloxyphenyl)pent-4-en-2-                                                yl]phenoxy]silane

Create Date:        2005-03-27

 

1,3-Benzenediol, o-(4-methylbenzoyl)-o’-(2-methoxybenzoyl)-

Present in GSO, PSO ,ONLY

Compound CID: 91715040

MF:                        C22H18O5

MW:                      362.4g/mol

InChIKey:            YKAUQBZMUPNUKE-UHFFFAOYSA-N

IUPAC Name:     [3-(4-methylbenzoyl)oxyphenyl] 2-methoxybenzoate

Create Date:        2015-04-28

 

2-Bromotetradecane

GSO, AVSO ONLY

Compound CID:  12798926

MF:                        C14H29Br

MW:                      277.28g/mol

InChIKey:            WZGQIDWFBFDMLE-UHFFFAOYSA-N

IUPAC Name:     2-bromotetradecane

Create Date:        2007-02-08

 

Cyclotrisiloxane, hexamethyl-

Present in GSO, PSO ,ONLY

Compound CID: 10914

MF:                        C6H18O3Si3

MW:                      222.46g/mol

InChIKey:            HTDJPCNNEPUOOQ-UHFFFAOYSA-N

IUPAC Name:     2,2,4,4,6,6-hexamethyl-1,3,5,2,4,6-trioxatrisilinane

Create Date:        2005-03-27

 

Isooctyl 3-mercaptopropionate

GSO ONLY

Compound CID:  104386

MF:                        C11H22O2S

MW:                      218.36g/mol

InChIKey:            ZHUWXKIPGGZNJW-UHFFFAOYSA-N

IUPAC Name:     6-methylheptyl 3-sulfanylpropanoate

Create Date:        2005-03-26

 

Squalene

Present in( PSO, ASO, AWSO, PGSO, AVSO

Compound CID:  638072

MF:                        C30H50

MW:                      410.7g/mol

InChIKey:            YYGNTYWPHWGJRM-AAJYLUCBSA-N

IUPAC Name:     (6E,10E,14E,18E)-2,6,10,15,19,23-                                  hexamethyltetracosa-2,6,10,14,18,22-hexaene

Create Date:        2004-09-16

 

Propanoic acid, 3-mercapto-, dodecyl ester

Present in GSO, AVSO

Compound CID:  80796

MF:                        C15H30O2S

MW:                      274.5g/mol

InChIKey:            ARNIBHATWCFIIK-UHFFFAOYSA-N

IUPAC Name:     dodecyl 3-sulfanylpropanoate

Create Date:        2005-03-26

 

1,2-15,16-Diepoxyhexadecane

Compound CID:  543423

MF:                        C16H30O2

MW:                      254.41g/mol

InChIKey:            KHOGZDMZNQXOFX-UHFFFAOYSA-N

IUPAC Name:     2-[12-(oxiran-2-yl)dodecyl]oxirane

Create Date:        2005-03-27

 

cis-Vaccenic acid

ASO ONLY

Compound CID: 5282761

MF:                        C18H34O2

MW:                      282.5g/mol

InChIKey:            UWHZIFQPPBDJPM-FPLPWBNLSA-N

IUPAC Name:     (Z)-octadec-11-enoic acid

Create Date:        2004-09-16

 

cis-11-Eicosenamide

Present in (ASO, AWSO, PGSO, AVSO

Compound CID:  5365374

MF:                        C20H39NO

MW:                      309.5g/mol

InChIKey:            LBHQTVBKPMHICN-KTKRTIGZSA-N

IUPAC Name:     (Z)-icos-11-enamide

Create Date:        2005-03-27

 

2-Furancarboxaldehyde, 5-methyl-

Present in (ASO)only

Compound CID:  12097

MF:                        C6H6O2

MW:                      110.11g/mol

InChIKey:            OUDFNZMQXZILJD-UHFFFAOYSA-N

IUPAC Name:     5-methylfuran-2-carbaldehyde

Create Date:        2005-03-27

 

dl-.alpha.-Tocopherol

Present in (ASO, AVSO)

Compound CID:  2116

MF:                        C29H50O2

MW:                      430.7g/mol

InChIKey:            GVJHHUAWPYXKBD-UHFFFAOYSA-N

IUPAC Name:     2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-                                3,4-dihydrochromen-6-ol

Create Date:        2005-03-25

 

4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl-

Present in (ASO, AWSO)

Compound CID: 119838

MF:                        C6H8O4

MW:                      144.12g/mol

InChIKey:            VOLMSPGWNYJHQQ-UHFFFAOYSA-N

IUPAC Name:     3,5-dihydroxy-6-methyl-2,3-dihydropyran-4-one

Create Date:        2005-03-27

 

5-Hydroxymethylfurfural

Present in (AWSO)

Compound CID:  237332

MF:                        C6H6O3

MW:                      126.11g/mol

InChIKey:            NOEGNKMFWQHSLB-UHFFFAOYSA-N

IUPAC Name:     5-(hydroxymethyl)furan-2-carbaldehyde

Create Date:        2005-03-26

 

Oleic Acid

Present in AWSO, AVSO

Compound CID: 445639

MF:                        C18H34O2

MW:                      282.5g/mol

InChIKey:            ZQPPMHVWECSIRJ-KTKRTIGZSA-N

IUPAC Name:     (Z)-octadec-9-enoic acid

Create Date:        2004-09-16

 

.alpha.-D-Glucopyranoside, O-.alpha.-D-glucopyranosyl-(1.fwdarw.3)-.beta.-D-fructofuranosyl

Present in AWSO

Compound CID:  220003

MF:                        C18H32O16

MW:                      504.4g/mol

InChIKey:            QWIZNVHXZXRPDR-UHFFFAOYSA-N

IUPAC Name:     2-[4-hydroxy-2,5-bis(hydroxymethyl)-2-[3,4,5-                            trihydroxy-6-(hydroxymethyl)oxan-2-                                                yl]oxyoxolan-3-yl]oxy-6-(hydroxymethyl)oxane-                 3,4,5-triol

Create Date:        2005-03-26

 

Palmitic Acid

Present in AWSO

Compound CID: 985

MF:                        C16H32O2

MW:                      256.42g/mol

InChIKey:            IPCSVZSSVZVIGE-UHFFFAOYSA-N

IUPAC Name:     hexadecanoic acid

Create Date:        2004-09-16

 

Levoglucosenone

Present in AWSO

Compound CID:  699486

MF:                        C6H6O3

MW:                      126.11g/mol

InChIKey:            HITOXZPZGPXYHY-UJURSFKZSA-N

IUPAC Name:     (1S,5R)-6,8-dioxabicyclo[3.2.1]oct-2-en-4-one

Create Date:        2004-09-16

 

Cyclopropanecarboxylic acid, 3-formyl-2,2-dimethyl-, ethyl ester

Present in AWSO

Compound CID: 566079

MF:                        C9H14O3

MW:                      170.21g/mol

InChIKey:            ZFZXRNVTYVRULM-UHFFFAOYSA-N

IUPAC Name:     ethyl 3-formyl-2,2-dimethylcyclopropane-1-                                  carboxylate

Create Date:        2005-03-27

 

1H-Inden-1-ol, 2,3-dihydro-

Present in AWSO

Compound CID: 22819

MF:                        C9H10O

MW:                      134.17g/mol

InChIKey:            YIAPLDFPUUJILH-UHFFFAOYSA-N

IUPAC Name:     2,3-dihydro-1H-inden-1-ol

Create Date:        2004-09-16

 

Phenol, 2,6-bis(1,1-dimethylethyl)-

Present in AWSO

Compound CID:  31405

MF:                        C14H22O

MW:                      206.32g/mol

InChIKey:            DKCPKDPYUFEZCP-UHFFFAOYSA-N

IUPAC Name:     2,6-ditert-butylphenol

Create Date:        2005-03-26

 

Chloro(2-methyloxiran-2-yl)acetic acid, t-butyl ester

Present in AWSO

Compound CID:  545402

MF:                        C9H15ClO3

MW:                      206.66g/mol

InChIKey:            SZVRMPXPAYKBKB-UHFFFAOYSA-N

IUPAC Name:     tert-butyl 2-chloro-2-(2-methyloxiran-2-                                   yl)acetate

Create Date:        2005-03-27

 

Cyclodecacyclododecene, 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18-octadecahydro-

Compound CID: 5377998

MF:                        C20H36

MW:                      276.5g/mol

InChIKey:            YNIDDVZQMSOPPE-VXPUYCOJSA-N

IUPAC Name:     (1Z)-bicyclo[10.8.0]icos-1(12)-ene

Create Date:        2005-03-27

 

2H-Pyran, 2-(7-heptadecynyloxy)tetrahydro-

Compound CID:  543312

MF:                        C22H40O2

MW:                      336.6g/mol

InChIKey:            ONANHJGDQJCYMD-UHFFFAOYSA-N

IUPAC Name:     2-heptadec-7-ynoxyoxane

Create Date:        2005-03-27

 

Androstan-17-one, 3-ethyl-3-hydroxy-, (5.alpha.)-

Compound CID:  14681481

MF:                        C21H34O2

MW:                      318.5g/mol

InChIKey:            SPKGPDRGORWGNP-SISSWOJJSA-N

IUPAC Name:     (5S,8R,9S,10S,13S,14S)-3-ethyl-3-hydroxy-10,13-                                dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-                                            dodecahydro-1H-cyclopenta[a]phenanthren-17-                         one

Create Date:        2007-02-09

 

Z,E-2,13-Octadecadien-1-ol

Compound CID: 5364462

MF:                        C18H34O

MW:                      266.5g/mol

InChIKey:            YCOMGIOWVNOOBC-YZDAJDCNSA-N

IUPAC Name:     (2Z,13E)-octadeca-2,13-dien-1-ol

Create Date:        2005-03-27

 

Chrysene, octadecahydro

Compound CID:  98460

MF:                        C18H30

MW:                      246.4g/mol

InChIKey:            ZEMKTMFBYLHVNN-UHFFFAOYSA-N

IUPAC Name:     1,2,3,4,4a,4b,5,6,6a,7,8,9,10,10a,10b,11,12,12a-                                octadecahydrochrysene

Create Date:        2005-03-26

 

Bicyclo[10.6.0]octadeca-1(12),15-diene

Compound CID:  5362802

MF:                        C18H30

MW:                      246.4g/mol

InChIKey:            VZCXNHIRQUVFRT-GROAESOISA-N

IUPAC Name:     (1Z,15Z)-bicyclo[10.6.0]octadeca-1(12),15-diene

Create Date:        2005-03-27

 

3-Chloropropionic acid, heptadecyl ester

Compound CID: 545757

MF:                        C20H39ClO2

MW:                      347g/mol

InChIKey:            UDESWCQJPWPMKY-UHFFFAOYSA-N

IUPAC Name:     heptadecyl 3-chloropropanoate

Create Date:        2005-03-27

 

1-Heptatriacotanol

Compound CID:  537071

MF:                        C37H76O

MW:                      537g/mol

InChIKey:            ZGJKNMPTVDDRRH-UHFFFAOYSA-N

IUPAC Name:     heptatriacontan-1-ol

Create Date:        2005-03-27

 

13-Docosenamide, (Z)-

Compound CID: 5365371

MF:                        C22H43NO

MW:                      337.6g/mol

InChIKey:            UAUDZVJPLUQNMU-KTKRTIGZSA-N

IUPAC Name:     (Z)-docos-13-enamide

Create Date:        2005-03-27

 

Caryophyllene oxide

Compound CID:  1742210

MF:                        C15H24O

MW:                      220.35g/mol

InChIKey:            NVEQFIOZRFFVFW-RGCMKSIDSA-N

IUPAC Name:     (1R,4R,6R,10S)-4,12,12-trimethyl-9-methylidene-                   5-oxatricyclo[8.2.0.04,6]dodecane

Create Date:        2005-07-12

 

Heptacosane

Compound CID:  11636

MF:                        C27H56

MW:                      380.7g/mol

InChIKey:            BJQWYEJQWHSSCJ-UHFFFAOYSA-N

IUPAC Name:     heptacosane

Create Date:        2004-09-16

 

.gamma.-Tocophero

Compound CID: 91738518

MF:                        C30H47F3O3

MW:                      512.7g/mol

InChIKey:            OWMUJRCXUOSNAV-UHFFFAOYSA-N

IUPAC Name:     [2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)-3,4-                         dihydrochromen-6-yl] 2,2,2-trifluoroacetate

Create Date:        2015-04-28

 

p-Menth-8-en-3-ol, acetate

Compound CID: 94579

MF:                        C12H20O2

MW:                      196.29g/mol

InChIKey:            HLHIVJRLODSUCI-ADEWGFFLSA-N

IUPAC Name:     [(1R,2S,5R)-5-methyl-2-prop-1-en-2-                                       ylcyclohexyl] acetate

Create Date:        2005-03-26

 

Sclaral (sclareolide lactol)

Compound CID:  537618

MF:                        C16H28O2

MW:                      252.39g/mol

InChIKey:            UZSSRRVZGDVPRE-UHFFFAOYSA-N

IUPAC Name:     3a,6,6,9a-tetramethyl-2,4,5,5a,7,8,9,9b-                                octahydro-1H-benzo[e][1]benzofuran-2-ol

Create Date:        2005-03-27

 

12-Methyl-E,E-2,13-octadecadien-1-ol

Compound CID:  90107969

MF:                        C19H36O

MW:                      280.5g/mol

InChIKey:            QQRKGLQLQDQGQI-WSGPNKEYSA-N

IUPAC Name:     (2E,13E)-12-methyloctadeca-2,13-dien-1-ol

Create Date:        2015-02-13

 

Phenol, 2,5-bis(1,1-dimethylethyl)-

Compound CID:  79983

MF:                        C14H22O

MW:                      206.32g/mol

InChIKey:            KDBZVULQVCUNNA-UHFFFAOYSA-N

IUPAC Name:     2,5-ditert-butylphenol

Create Date:        2005-03-26

 

2-Acetoxy-1,1,10-trimethyl-6,9-epidioxydecalin

Compound CID:  538309

MF:                        C15H24O4

MW:                      268.35g/mol

InChIKey:            GNQFBOZHHSYHCB-UHFFFAOYSA-N

IUPAC Name:     (2,2,6-trimethyl-9,10-                                                         dioxatricyclo[6.2.2.01,6]dodecan-3-yl) acetate

Create Date:        2005-03-27

 

3H-3,10a-Methano-1,2-benzodioxocin-3-ol, octahydro-7,7-dimethyl-, (3.alpha.,6a.beta.,10a.beta.)-

Compound CID:  606210

MF:                        C13H22O3

MW:                      226.31g/mol

InChIKey:            RBFWHMUVCHUYON-UHFFFAOYSA-N

IUPAC Name:     5,5-dimethyl-11,12-                                                                            dioxatricyclo[8.2.1.01,6]tridecan-10-ol

Create Date:        2005-03-27

 

Tricyclo[4.3.0.0(7,9)]nonane, 2,2,5,5,8,8-hexamethyl-, (1.alpha.,6.beta.,7.alpha.,9.alpha.)-

Compound CID:  549738

MF:                        C15H26

MW:                      206.37g/mol

InChIKey:            PUJIBQKSZBPAMT-UHFFFAOYSA-N

IUPAC Name:     2,2,5,5,8,8-hexamethyltricyclo[4.3.0.07,9]nonane

Create Date:        2005-03-27

 

GSO: Grape (Vitis vinifera) extracts; PSO: Plum (Prunus subg. Prunus: Mirabelles) extracts; ASO: Apple (Malus domestic) extracts; AWSO: Ajwa dates (Phoenix dactylifera L) extracts; PGSO: Pomegranate (Punica granatum) extracts; AVSO: Avocado ( Persea Americana) extracts.

Table 7: Results of the GC-MS chromatogram of the selected compounds in studied seeds (GSO, PSO, ASO, AWSO, PGSO and AVSO).

Docking Protein (Epinephrine Receptor PDB: 2rh1) with the Ligand (Seeds GSO, PSO, ASO, AWSO, PGSO and AVSO) Phytochemical Molecule and the ACE2 Receptor

The epinephrine receptor PDB: 2rh1 and ACE2 receptor 3D0G (Table 8) showed binding energy with the six studied seeds in the current study’s oils extracts 44 ligands (Table 9). Table 9 reflects the binding affinity of 44 ligands to both investigated receptors. These docking studies showed that among the seed extract phytochemicals, the stigmastan-3,5-diene (compound CID: 525918, MF: C29H48) component of GSO, PSO, AWSO, PGSO and AVSO had the highest binding affinity of -11.4 kcal/mole and -11.6 kcal/mole, with 2rh1 and 3D0G, respectively. Moreover, the levoglucosenone (compound CID: 699486, MF: C6H6O3) component of AWSO extract had the lowest binding affinity at -4.8 kcal/mole and 5.5 kcal/mole with 2rh1 and 3D0G, respectively, as given in Table 10. The ligands with the best possible affinity to the receptor 2rh1 and ACE2 receptor 3D0G are outlined in Table 10, while the comparison of the highest binding energy is provided in Fig. 2.

Figure 2: Comparison between the highest binding affinity (kcal/mole) interaction of 44 ligands of GSO, PSO, ASO, AWSO, PGSO and AVSO with the β2 adrenoreceptor (2rh1) and ACE2 receptor (3D0G) in the AutoDock analysis. (GSO: Grapes (Vitis vinifera) extracts; PSO: Plum (Prunus subg. Prunus: Mirabelles) extracts; ASO: Apple (Malus domestic) extracts; AWSO: Ajwa dates (Phoenix dactylifera L) extracts; PGSO: Pomegranate (Punica granatum) extracts; AVSO: Avocado (Persea Americana) extracts).

Target

Target protein receptor (PDB)

1-Epinephrine (adrenaline)

To potential antistress

β2 adrenoreceptor (PDB: 2rh1​)

3D structure of 2rh1

Deposition author(s): Cherezov, V., Rosenbaum, D.M., Hanson, M.A., Rasmussen, S.G.F., Thian, F.S., Kobilka, T.S., Choi, H.J., Kuhn, P., Weis, W.I., Kobilka, B.K., Stevens, R.C., Accelerated Technologies Center for Gene to 3D Structure (ATCG3D), GPCR Network (GPCR).

2-Angiotensin-converting enzyme 2 The ACE2 receptor

The SARS-CoV-2 virus requires ACE2 to infect cells

to potential new clinical trial tests ACE inhibitor against SARS-CoV-2

3D0G

  • Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus human strain complexed with human-civet chimeric receptor ACE2
  • -DOI: 10.2210/pdb3D0G/pdb
  • -Classification: HYDROLASE
  • -Organism(s): Paguma larvata, Homo sapiens, Severe acute respiratory syndrome-related coronavirus
  • -Expression System: Spodoptera frugiperda
  • -Mutation(s): No
  • -Deposited: 2008-05-01 Released: 2008-07-08

-Deposition Author(s): Li, F.

3D structure of 3D0G

Table 8: The target receptors used in AutoDock analysis.

Compounds separated by GC–MS

Chemical

(PubChem CID:)

AutoDock analysis results with 2rh1

AutoDock analysis results with 3D0G

9-Octadecenamide, (Z)-

Or

Oleamide

Present in all(GSO, PSO, ASO, AWSO, PGSO, AVSO)

Compound CID: 5283387

 

 

  

Stigmastan-3,5-diene

Present in (GSO, PSO, AWSO, PGSO, AVSO)

Compound CID: 525918

 

 

  

Hexadecanamide

Present in all(GSO, PSO, ASO, AWSO, PGSO, AVSO

Compound CID: 69421

 

  

Pentanoic acid, 5-hydroxy-, 2,4-di-t-butylphenyl esters

Present in GSO, PSO , PGSO

Compound CID: 605777

 

  

Methyl stearate

GSO, PSO ONLY

Compound CID: 8201

 

  

1,3-Benzenediol, o-(4-methylbenzoyl)-o’-(2-methoxybenzoyl)-

Present in GSO, PSO, ONLY

Compound CID: 91715040

 

  

2-Bromotetradecane

GSO, AVSO ONLY

Compound CID: 12798926

 

  

Isooctyl 3-mercaptopropionate

GSO ONLY

Compound CID: 104386

 

  

Squalene

Present in( PSO, ASO, AWSO, PGSO, AVSO

Compound CID: 638072

 

 

  

Propanoic acid, 3-mercapto-, dodecyl ester

Present in GSO, AVSO

Compound CID: 80796

 

 

  

1,2-15,16-Diepoxyhexadecane

Compound CID: 543423

 

 

  

cis-Vaccenic acid

ASO ONLY

Compound CID: 5282761

 

  

cis-11-Eicosenamide

Present in (ASO, AWSO, PGSO, AVSO

Compound CID: 5365374

 

  

2-Furancarboxaldehyde, 5-methyl-

Present in (ASO)only

Compound CID: 12097

 

 

  

dl-.alpha.-Tocopherol

Present in (ASO, AVSO)

Compound CID: 2116

 

  

4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl-

Present in (ASO, AWSO)

Compound CID: 119838

 

  

5-Hydroxymethylfurfural

Present in (AWSO)

Compound CID: 237332

 

  

Oleic Acid

Present in AWSO, AVSO

Compound CID: 445639

 

  

.alpha.-D-Glucopyranoside, O-.alpha.-D-glucopyranosyl-(1.fwdarw.3)-.beta.-D-fructofuranosyl

Present in AWSO

Compound CID: 220003

 

 

  

Palmitic Acid

Present in AWSO

Compound CID: 985

 

  

Levoglucosenone

Present in AWSO

Compound CID: 699486

 

 

  

Cyclopropanecarboxylic acid, 3-formyl-2,2-dimethyl-, ethyl ester

Present in AWSO

Compound CID: 566079

 

  

1H-Inden-1-ol, 2,3-dihydro-

Present in AWSO

Compound CID: 22819

 

  

Phenol, 2,6-bis(1,1-dimethylethyl)-

Present in AWSO

Compound CID: 31405

  

Chloro(2-methyloxiran-2-yl)acetic acid, t-butyl ester

Present in AWSO

Compound CID: 545402

 

 

  

Cyclodecacyclododecene, 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18-octadecahydro-

Present in AVSO

Compound CID: 5377998

 

  

2H-Pyran, 2-(7-heptadecynyloxy)tetrahydro-

Present in AVSO

Compound CID: 543312

 

  

Androstan-17-one, 3-ethyl-3-hydroxy-, (5.alpha.)-

Present in AVSO

Compound CID: 14681481

 

  

Z,E-2,13-Octadecadien-1-ol

Present in AVSO

Compound CID: 5364462

 

  

Chrysene, octadecahydro

Present in AVSO

Compound CID: 98460

 

  

Bicyclo[10.6.0]octadeca-1(12),15-diene

Present in AVSO

Compound CID: 5362802

 

  

3-Chloropropionic acid, heptadecyl ester

Present in AVSO

Compound CID: 545757

 

  

1-Heptatriacotanol

Present in AVSO

Compound CID: 537071

 

  

13-Docosenamide, (Z)-

Present in AVSO

Compound CID: 5365371

 

  

Caryophyllene oxide

Present in AVSO

Compound CID: 1742210

 

 

  

Heptacosane

Present in AVSO

Compound CID: 11636

 

  

.gamma.-Tocophero

Present in AVSO

Compound CID: 91738518

 

  

p-Menth-8-en-3-ol, acetate

Present in AVSO

Compound CID: 94579

 

  

Sclaral (sclareolide lactol)

Present in AVSO

Compound CID: 537618

 

  

12-Methyl-E,E-2,13-octadecadien-1-ol

Present in AVSO

Compound CID: 90107969

 

  

Phenol, 2,5-bis(1,1-dimethylethyl)-

Present in AVSO

Compound CID: 79983

 

  

2-Acetoxy-1,1,10-trimethyl-6,9-epidioxydecalin

Present in AVSO

Compound CID: 538309

 

 

  

3H-3,10a-Methano-1,2-benzodioxocin-3-ol, octahydro-7,7-dimethyl-, (3.alpha.,6a.beta.,10a.beta.)-

Present in AVSO

Compound CID: 606210

 

  

Tricyclo[4.3.0.0(7,9)]nonane, 2,2,5,5,8,8-hexamethyl-, (1.alpha.,6.beta.,7.alpha.,9.alpha.)-

Present in AVSO

Compound CID: 549738

 

  

Table 9: Results of the GC-MS analysis of the studied seed extracts (GSO, PSO, ASO, AWSO, PGSO and AVSO) with the AutoDock analysis as potential ligand binding to the β2 adrenoceptor (2rh1) and ACE2 receptor (3D0G).

Compounds

Chemical (PubChem CID)

Global binding energy of the highest binding affinity (kcal/mole) with 2rh1

with the best enlarged angle for ligand with the protein

 

Global binding energy of the highest binding affinity (kcal/mole) with3D0G

with the best enlarged angle for ligand with the protein

9-Octadecenamide, (Z)-

Or

Oleamide

Present in all(GSO, PSO, ASO, AWSO, PGSO, AVSO)

Compound CID: 5283387

MF: C18H35NO

-7.9

-8.7

 

 

 

Stigmastan-3,5-diene

Present in (GSO, PSO, AWSO, PGSO, AVSO)

Compound CID: 525918

MF: C29H48

-11.4

-11.6

Hexadecanamide

Present in all(GSO, PSO, ASO, AWSO, PGSO, AVSO

Compound CID: 69421

MF: C16H33NO

-6.6

-7.7

Pentanoic acid, 5-hydroxy-, 2,4-di-t-butylphenyl esters

Present in GSO, PSO, PGSO

Compound CID: 605777

MF: C19H30O3

-10.2

-10.1

Methyl stearate

GSO, PSO ONLY

Compound CID: 8201

MF: C19H38O2

-6.0

-5.7

1,3-Benzenediol, o-(4-methylbenzoyl)-o’-(2-methoxybenzoyl)-

Present in GSO, PSO ,ONLY

Compound CID: 91715040

MF: C22H18O5

-10.3

-9.5

2-Bromotetradecane

GSO, AVSO ONLY

Compound CID: 12798926

MF: C14H29Br

-5.4

-6.1

Isooctyl 3-mercaptopropionate

GSO ONLY

Compound CID: 104386

MF: C11H22O2S

-6.4

-7.2

Squalene

Present in( PSO, ASO, AWSO, PGSO, AVSO

Compound CID: 638072

MF: C30H50

-10.6

-9.7

Propanoic acid, 3-mercapto-, dodecyl ester

Present in GSO, AVSO

Compound CID: 80796

MF: C15H30O2S

-6.7

-6.5

1,2-15,16-Diepoxyhexadecane

Compound CID: 543423

MF: C16H30O2

-5.8

-6.3

cis-Vaccenic acid

ASO ONLY

Compound CID: 5282761

MF: C18H34O2

-8.2

-9.3

cis-11-Eicosenamide

Present in (ASO, AWSO, PGSO, AVSO

Compound CID: 5365374

MF: C20H39NO

-7.5

-7.5

2-Furancarboxaldehyde, 5-methyl-

Present in (ASO)only

Compound CID: 12097

MF: C6H6O2

-5.2

-5.5

dl-.alpha.-Tocopherol

Present in (ASO, AVSO)

Compound CID: 2116

MF: C29H50O2

-10.2

-9.2

4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl-

Present in (ASO, AWSO)

Compound CID: 119838

MF: C6H8O4

-5.5

-5.5

5-Hydroxymethylfurfural

Present in (AWSO)

Compound CID: 237332

MF: C6H6O3

-5.2

-5.8

Oleic Acid

Present in AWSO, AVSO

Compound CID: 445639

MF: C18H34O2

-6.9

-7.5

.alpha.-D-Glucopyranoside, O-.alpha.-D-glucopyranosyl-(1.fwdarw.3)-.beta.-D-fructofuranosyl

Present in AWSO

Compound CID: 220003

MF: C18H32O16

-9.0

-9.2

Palmitic Acid

Present in AWSO

Compound CID: 985

MF: C16H32O2

-6.2

-6.8

Levoglucosenone

Present in AWSO

Compound CID: 699486

MF: C6H6O3

-4.8

-5.5

Cyclopropanecarboxylic acid, 3-formyl-2,2-dimethyl-, ethyl ester

Present in AWSO

Compound CID: 566079

MF: C9H14O3

-5.5

-5.9

1H-Inden-1-ol, 2,3-dihydro-

Present in AWSO

Compound CID: 22819

MF: C9H10O

-6.4

-8.1

Phenol, 2,6-bis(1,1-dimethylethyl)-

Present in AWSO

Compound CID: 31405

MF: C14H22O

-7.5

-9.2

Chloro(2-methyloxiran-2-yl)acetic acid, t-butyl ester

Present in AWSO

Compound CID: 545402

MF: C9H15ClO3

-6.1

-6.6

Cyclodecacyclododecene, 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18-octadecahydro-

Compound CID: 5377998

MF: C20H36

-10.2

-10.9

2H-Pyran, 2-(7-heptadecynyloxy)tetrahydro-

Compound CID: 543312

MF: C22H40O2

-6.6

-6.2

Androstan-17-one, 3-ethyl-3-hydroxy-, (5.alpha.)-

Compound CID: 14681481

MF: C21H34O2

-10.7

-11.5

Z,E-2,13-Octadecadien-1-ol

Compound CID: 5364462

MF: C18H34O

-6.7

-6.9

Chrysene, octadecahydro

Compound CID: 98460

MF: C18H30

-9.6

-11.5

Bicyclo[10.6.0]octadeca-1(12),15-diene

Compound CID: 5362802

MF: C18H30

-9.2

-10.6

3-Chloropropionic acid, heptadecyl ester

Compound CID: 545757

MF: C20H39ClO2

-7.4

-6.8

1-Heptatriacotanol

Compound CID: 537071

-5.3

-4.6

13-Docosenamide, (Z)-

Compound CID: 5365371

MF: C22H43NO

-8.8

-8.6

Caryophyllene oxide

Compound CID: 1742210

MF: C15H24O

-8.6

-10.4

Heptacosane

Compound CID: 11636

MF: C27H56

-5.9

-5.0

.gamma.-Tocophero

Compound CID: 91738518

MF: C30H47F3O3

-10.0

-8.8

p-Menth-8-en-3-ol, acetate

Compound CID: 94579

MF: C12H20O2

-7.7

-9.0

Sclaral (sclareolide lactol)

Compound CID: 537618

MF: C16H28O2

-9.2

-9.7

12-Methyl-E,E-2,13-octadecadien-1-ol

Compound CID: 90107969

MF: C19H36O

-6.4

-7.0

Phenol, 2,5-bis(1,1-dimethylethyl)-

Compound CID: 79983

-7.8

-9.1

2-Acetoxy-1,1,10-trimethyl-6,9-epidioxydecalin

Compound CID: 538309

MF: C15H24O4

-8.7

-10.9

3H-3,10a-Methano-1,2-benzodioxocin-3-ol, octahydro-7,7-dimethyl-, (3.alpha.,6a.beta.,10a.beta.)-

Compound CID: 606210

MF: C13H22O3

-8.2

-10.4

Tricyclo[4.3.0.0(7,9)]nonane, 2,2,5,5,8,8-hexamethyl-, (1.alpha.,6.beta.,7.alpha.,9.alpha.)-

Compound CID: 549738

MF: C15H26

-8.8

-10.8

Synergetic

 

Mean =7.66

Mean =-8.35

Table 10: Prediction of the best interaction of the ligands of GSO, PSO, ASO, AWSO, PGSO and AVSO with β2 adrenoreceptor (2rh1) and ACE2 receptor (3D0G) in the AutoDock analysis.

Discussion

The coronavirus pandemic has had many consequences, including health, psychological and economic consequences. The World Health Organization approved a group of drugs to treat the virus. Besides the drugs, there are ongoing races in production of vaccines. Furthermore, scientists are increasingly focusing their efforts to discover vaccines without side effects. However, the discovery of novel coronavirus mutations requires more attention and considerations and varied drugs and vaccine proposals; for example, phytochemistry potential trials.

Phytochemicals in fruits, vegetables and plant parts hold secondary metabolites and their essential metabolites have several inherent biological activities that involve antimicrobial, anti-inflammatory and inhibitory enzyme properties with health benefits [30,31]. In our previous studies, avocado and pomegranate juice, peel and seed oil ameliorated toxicity and decreased inflammation, oxidative stress and apoptosis induced by CCl4 and DEN [21,32-35].

Grape (Vitis vinifera) was introduced to the literature as a treatment after an arb doctor suggested it as a royal oil for skin treatment for Ferdinand IV in the 14th century. It also has antioxidant and anti-inflammatory properties, according to the previous investigation. The seed composition of fruits depends on maturation, the environmental cultivation state and extraction protocol [36-38]. The results of the current study’s seed extract analysis (Table 1-7) showed that Grape Seed Oil (GSO) included 9-octadecenamide, (z)-, stigmastan-3, 5-diene, 9, 12-octadecadienoic acid (z, z)-, methyl ester, oleamide, hexadecanamide and phosphoric acid trimethyl ester. Furthermore, GSO was found to contain dodecyl acrylate, pentanoic acid, 5-hydroxy-, 2,4-di-t-butylphenyl esters, methyl stearate and 1-pentadecyne. It also included 1-pentadecyne, 11, 13-dimethyl-12-tetradecen-1-ol acetate, 4-methyl-2,4-bis(4′-trimethylsilyloxyphenyl)pentene-1, 1,3-benzenediol, o-(4-methylbenzoyl)-o’-(2-methoxybenzoyl)-, 2-bromotetradecane, cyclotrisiloxane, hexamethyl- and isooctyl 3-mercaptopropionate (Table 1).

GSO compositions such as 9-octadecenamide, (z)-, 9,12-octadecadienoic acid (z, z)-, oleamide and hexadecanamide have a sedative effect where a group of an amide of the fatty acid oleic acid is located as naturally endogenous on the animal’s body. It has an accumulation function in the cerebrospinal fluid during sleep deprivation and influences animal’s sleep, making those oleamide derivatives potential treatments for mood, depression and sleep disorders through interaction with multiple neurotransmitters. Further, it binds the Cannabinoid receptor type 1 (CB1) receptor as a full agonist. Also, these derivatives have anti-corrosive properties [39-42]. Stigmastane, 24R-ethylcholestane, is a tetracyclic triterpene and cholestane as well as ergostane. This sterane is applied as a biomarker for initial eukaryotes. Stigmastanol, Stigmastan-3, 5-diene and their derivatives are types of plant phytosterol that inhibit cholesterol absorption from the diet [43]. Acrylates are the salts, esters and conjugate bases of acrylic acid, including dodecyl acrylate, for example. They have various bifunctional functionalities such as in the polymers industry and as antimicrobial and non-chemical based antioxidant agents [44-46]. GSO also contains phosphoric acids that are not genotoxic nor carcinogenic and is therefore used as a food additive in water treatment products. Further, it is used as phosphate salts for fertilizers, dental cement, albumin derivatives and the sugar and textile industries [47].

GSO contains a group of ester, acetate and valeric or pentanoic acids; all have pleasant odors and are used in the perfume and cosmetic additives industry. Valeric acid is a minor product of the gut microbiome and can also be produced by its esters’ metabolism found in food [48,49]. The repair of these acid levels in the gut has been recommended as the mechanism in the govern of the clostridioides difficile infection after fecal microbiota transplant [49].

Methyl stearate is a fatty acid methyl ester and octadecanoate ester. Stearic acid has a role as a metabolite and is connected with reduced LDL cholesterol compared to other saturated fatty acids. It is used in lubricants, detergents, softening agents, release agents and food additives, as well as in batteries and electronic devices [50,51].

GSO contains different bioactive secondary metabolites such as sulfurous acid, 2-ethylhexyl isohexyl ester, heptacosane, dodecyl pentyl ester, eicosane 2- methyl, benzyl detervitive and 2-bromotetradecane, dodecyl acrylate as well as 1,3-benzenediol, o-(4-methylbenzoyl)-o’-(2-methoxybenzoyl)-. These combinations of secondary metabolites are related to antibacterial, antifungal and anti-diabetic attributes [52-55]. Other metabolites such as 4-methyl-2, 4-bis (4-hydroxyphenyl) pent-1-ene (MBP) have potent estrogenic action in-vitro and in-vivo; moreover, computer modelling has revealed that this greater strength is due to more effective binding to estrogen receptors. Previous studies reported that cyclotrisiloxane and hexamethyl- derivatives have antioxidant and antibacterial activity. GSO contains isooctyl 3-mercaptopropionate that depravities reported antioxidant and anti-inflammatory [56-59].

A plum is a fruit of a unique species, Prunus subg. Prunus. Plum stones include a seed with a high content of proteins and lipids that are frequently underused and undervalued. Victoria Plum Seed Oil extract (PSO) includes phytosterols such as stigmastan-3, 5-diene and hexadecanamide derivatives also found in current grape seed extract (Table 2). PSO contains esters, methyl stearate, dodecyl acrylate and benzyl detectives, which have beneficial antibacterial, anti-inflammatory, anticancer and antioxidant effects, as was discussed before concerning grape seed oil extract with the relative value of RT: Retention Times (minutes). PSO comprises squalene, a natural organic polyunsaturated hydrocarbon of the triterpene type know as shark liver oil. All plants, animals, birds and human livers provide squalene as a biochemical intermediate. It preserves polyunsaturated fatty acids against temperature-dependent autoxidation. Squalene also functions essentially as a peroxyl radical scavenger, is useful for skin hydration, works as an antioxidant, has antitumor properties and is used in cosmetics [60,61].

Apple seeds are rich in proteins, carbohydrates and minerals, making them useful as feed or fertilizer [62]. Moreover, they contain fatty linoleic acid, sterols, tocopherols, a primary fatty amid cis-11-eicosenamide and hydrocarbons, especially squalene 63, which is confirmed by the present study’s apple seed oil GC-MS analysis. Previous investigations reported that apple seed oil can improve the treatment of various diseases, especially Cardiovascular Disease (CVD) and diabetic disorder. This improvement is effected by managing the blood lipid profile, blood pressure, adipocyte hormones, inflammatory response, endothelial capacity and through numerous other beneficial effects as anticancer, antioxidant and antibacterial properties [64,65]. Moreover, dl-.alpha.-tocopherol (vitamin E) was reported as an antidepressant and significant antioxidant [63-65]. Apple Seed Oil (ASO) contains hexadecanamide, benzoic acid fatty acid esters and -octadecenoic acid and their derivatives, which have beneficial antibacterial, anti-inflammatory, anticancer and antioxidant effects, as discussed before regarding grape seed oil and plum seed oil. Apple seeds oil, also rich in fatty acids such as vaccenic acid, is an omega-7 fatty acid with antibacterial, antioxidant and anti-coronary heart disease properties [66,67]. ASO includes 2-pyrrolidinovalerophenone, which is used as a bath salt and has a neurological effect and 2-furancarboxaldehyde, 5-methyl-F, which is a derivative inhibiting sickle cell formation in the blood.

Additionally, it contains radical scavenging activity compounds such as 13-Tetradecenal. This is because plum, grape and apple seeds have a phenolic composition with antioxidant capacity, comprising 4H-pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl- and 9,12-octadecadienoic acid (Z, Z)- and phenylmethyl ester [68-71].

Date palm (Phoenixdactylifera) is a member of the palm family (Arecaceae) and has been used as food for over 6000 years. It is found in Saudi Arabia, Middle Eastern countries and Egypt. Its components such as carbohydrates, phytochemicals, sterols, carotenes and flavonoids have been screened for numerous therapeutic activities and are found to decrease the side effects of manufactured medicines that hurt the human biological system. Besides, date seeds are used as animal feed or caffeine-free coffee replacements in some areas. The Ajwa date seed oil includes sterol, phytochemistry, oleic, palmitic and fatty acids and their derivatives; these have antibacterial, antioxidant, anticancer and antilipidemic effects [72,73]. The present work reported that Ajwa date seed oil (AWSO) contains hexadecanamide, 5-hydroxymethylfurfura, 9-octadecenamide, (Z)-, oleic acid, cis-11-eicosenamide, dodecanoic acid and palmitic acid. Squalene and stigmastan-3,5-diene are found in it. AWSO contains fatty acid ester, other phenol and furfural derivatives, as presented in Table 4. These compounds have antioxidant and anti-inflammatory, neurological, sedation and cosmetic effects. Moreover, it contains 7-methyl-Z-tetradecen-1-of acetate, which has the effect of heat and heat cough [74].

The present work reported that pomegranate (Punica granatum L.), which belongs to the Punicaceae famil (PGSO), contains hexadecanamide, 5-hydroxymethylfurfural, 9-octadecenamide, (Z)-, oleamide, cis-11-eicosenamide, dodecyl acrylate and fatty acid ester, as well as phenol, squalene, stigmastan-3,5-diene (Table 5). These compounds have antioxidant and anti-inflammatory effects [19]. Avocados (Percea Americana) are related to the Lauraceae family. Avocados contain carotenoids, minerals, phenolics, vitamins and fatty acids. Further, avocados have lipid-lowering, antihypertensive, antidiabetic, anti-obesity, antithrombotic, antiapoptosis and anti-atherosclerotic cardio-protective effects. The avocado seeds are considered one of the fruit’s non-edible parts, which are generally discarded as trash and can cause environmental problems. Examining such foods’ underutilized dietary and therapeutic potential will also diminish the environmental waste load [33,75].

The composition of avocado seed includes protein, fat, ash, moisture, fiber and carbohydrate, minerals such as Ca, Zn, K, Na, P, Fe, Cu, Pb and Co) phytochemicals (flavinoid, tanine, saponine, total phenolics, antioxidant capacity, oxalates, phytates and alkaloids) and vitamins (A, B1, B2, B3, C and E). The avocado seeds have antioxidant and antimicrobial, antihypertensive, fungicidal, larvicidal, hypolipidemic, amoebicidal and giardicidal activities [76].

The present study indicated that AVSO contains many fatty acids and their derivatives (Table 6), such as linoleyl alcohol and carboxamide derived from palmitic acid and volatile compounds, for example, cyclodecacyclododecene, 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18-octadecahydro-, hexadecanamide, 9-octadecenamide, (Z)-, 2H-pyran and 2-(7-heptadecynyloxy)tetrahydro. AVSO includes steroids such as androstan-17-one, 3-ethyl-3-hydroxy-, (5.alpha.) and the polycyclic aromatic hydrocarbon chrysene, octadecahydro. Also, its composition of 11-eicosenoic acid, monounsaturated omega-9 fatty, dl-.alpha.-tocopherol and gamma.-tocophero shows antioxidant activity. AVSO includes bicyclic organic compounds such as bicyclo[10.6.0]octadeca-1(12),15-diene as well as antitumor cis-10-nonadecenoic acid, monounsaturated fatty cis-10-nonadecenoic acid [77-79].

AVSO contains many essential and volatile oils, ester derivatives, farnesol isomer, heptacosane and 3-chloropropionic acid, heptadecyl este. Caryophyllene oxide has chemopreventative, anti-tumor and antifungal properties and is used in approved food flavoring and other benzyl, organic and aromatic derivatives, as indicated in Table 6 [80,81]. It yields antioxidant compounds such as oleic acid, stigmastan-3,5-diene and antifungal cosmetics agents such as sclaral (sclareolide lactol) [82].

Molecular docking is a theoretical simulation system based on bioinformatics, which depends on the cooperation between molecules (such as ligands and receptors) and predicts their binding modes and affinity by computer investigation. Molecular docking works as an acceptable tool in medicinal chemistry for fields such as structure-based analytical drugs. Various original studies corresponding to biomolecular cooperation in food pattern and phytochemistry have continuously evolved. The remarkable benefits of molecular docking, such as predicting procedures with fewer experiments and limiting the decline of material in trials, have led to the consideration of its possible administration in various areas. In docking complex binding energy, the lowest energy positions designate the highest binding affinity, as high energy creates variable conformations that assist in pharmacological experiments. Our previous work on rat and human investigations showed that the treatment effect of vitamin B and agarwood extracts confirmed by molecular docking might be due to their role as inverse agonists, reversing the induction of stress and depression by epinephrine with many medicinal properties, such as sedative, anti-inflammatory and anti-apoptotic effects [10]. The present work described the investigated compounds in the seed extracts have a potential binding mode with the β2 adrenoreceptor (2rh1) and ACE2 receptor (3D0G) by docking analysis (Table 9,10). Further, the inhibitory effect of synergetic extract compounds was also reported. The present finding established the seed compounds’ ameliorating effect against both studied receptors and might represent the studied extract as an inverse agonist ligand for depression and infection in the COVID-19 pandemic.

We have future application possibilities in using the currently investigated seed oil extracts in manufacture as endogenous nanoparticles as drugs carrier or vaccines to target cell receptors and prolong their circulation time. Moreover, as the seed oil extract is present in fruit and is edible, it will help decrease the side effects that are likely to occur due to nanoparticles, vaccines and drugs in the surrounding and body tissue.

Many bioactive phytochemicals and herbal medicines have low solubility in aqueous media, poor bioavailability, poor stability and toxicity-dose dependence, so scientists have used nanotechnology to overcome these disadvantages and deliver bioactive phytochemicals to the target with higher efficiency, using encapsulation. For this goal, nanoparticles can be provided in various forms, sizes and combinations and adjusted physicochemically to accomplish particular characteristics, depending on the features of both the bioactive molecule and the target cell, such as an inorganic gold atom (molecular weight = 196.96657 g/mol) or organic liposome (molecular weight = 938.1 g/mol). Unfortunately, there are challenges such as the potential toxicity of nanoparticles, such as immunotoxicity, the toxicity of surfactants and co-surfactants or emulsifier nanocarriers, long-term toxicity due to chronic exposure and the accumulation as well as overaccumulation of nanoparticles at all barriers before acting on the targeted cells. The analyzed seed oil contents’ binding energy with the currently studied receptors enables them to be future nanoparticles in vaccines and drugs. Further, the molecular weight allows them to be nanocarriers [83-86].

Conclusion

In this investigation, the binding interactions of 44 phytoconstituents were carried out against the β2 adrenoreceptor (2rh1) and the ACE2 receptor, 3D0G. All the currently studied seed oil extract constituent were identified by gas chromatography-mass spectrometry and studied. The present investigation strongly suggests the application of these seed oil extracts to ameliorate depression and decrease and prevent infection in the COVID pandemic. Further studies need to be carried out to examine these compounds’ pharmacological properties and inhibitory potentials require experimental models.

Author Contributions

A.F.H. contributed to creating and owning, conceptualizing, work idea designing and performing the experiments, chromatography and AutoDock analysis, interpreting and analyzing data, writing, revising and editing the manuscript and explaining the results. T.M.F. contributed to the AutoDock analysis and formatting manuscript. I.M.A, I.A.K, M.E.O, M.A.A and F.M.A. contributed to the doing practical of the chromatography portion of the study.

Ethical Statement

This research did not include any human subjects or animal experiments.

References

  1. Ordoudi S, Bakirtzi C, Tsimidou M. The potential of tree fruit stone and seed wastes in greece as sources of bioactive ingredients. Recycling. 2018;3(1):9.
  2. Martin ME, Grao-Cruces E, Millan-Linares MC, Montserrat-de la Paz S. Grape (Vitis vinifera L.) Seed oil: a functional food from the winemaking industry. Foods. 2020;9(10):1360.
  3. Gorodyska O, Grevtseva N, Samokhvalova O, Gubsky S. Determination of the chemical composition of grape seed powders by GC-MS analysis. Eureka Life Sci. 2018;6(6):3-8.
  4. Felhi S, Baccouch N, Salah HB, Smaoui S, Allouche N, Gharsallah N, et al. Nutritional constituents, phytochemical profiles, in vitro antioxidant and antimicrobial properties and gas chromatography-mass spectrometry analysis of various solvent extracts from grape seeds (Vitis vinifera L.). Food Sci Biotechnol. 2016;25(6):1537-44.
  5. Yehualashet AS, Belachew TF. Aceis and arbs and their correlation with covid-19: A review. Infect Drug Resist. 2020;13:3217-24.
  6. Yu LL, Malik Peiris JS. Pathogenesis of severe acute respiratory syndrome. Curr Opin Immunol. 2005;17(4):404-10.
  7. Perico L, Benigni A, Remuzzi G. Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade. Nephron. 2020;144(5):213-21.
  8. Brojakowska A, Narula J, Shimony R, Bander J. Clinical Implications of SARS-CoV-2 interaction with renin angiotensin system: JACC review topic of the week. J Am Coll Cardiol. 2020;75(24):3085-95.
  9. Mosli M, Alourfi M, Alamoudi A, Hashim A, Saadah O, Al Sulais E, et al. A cross-sectional survey on the psychological impact of the COVID-19 pandemic on inflammatory bowel disease patients in Saudi Arabia. Saudi J Gastroenterol. 2020;26(5):263.
  10. Hamouda A. A pilot study of antistress effects of vitamin b complex and agarwood extract in an animal model with parallel observations on depression in human subjects. J Drug Alcohol Res. 2021;11.
  11. Lezama-Martínez D, Valencia-Hernández I, Flores-Monroy J, Martínez-Aguilar L. Combination of β adrenergic receptor block and renin–angiotensin system inhibition diminished the angiotensin II-induced vasoconstriction and increased bradykinin-induced vasodilation in hypertension. Dose-Response. 2017;15(4):1-7.
  12. Yonemochi H, Yasunaga S, Teshima Y, Iwao T, Akiyoshi K, Nakagawa M, et al. Mechanism of β-adrenergic receptor upregulation induced by ACE inhibition in cultured neonatal rat cardiac myocytes: roles of bradykinin and protein kinase C. Circulation. 1998;97(22):2268-73.
  13. Natesan V. SARS-CoV-2 host cell entry might involve beta adrenergic receptors. OSF Preprints. 2020.
  14. Chis IC, Ungureanu MI, Marton A, Simedrea R, Muresan A, Postescu ID, et al. Antioxidant effects of a grape seed extract in a rat model of diabetes mellitus. Diabetes Vasc Dis Res. 2009;6(3):200-4.
  15. Sreemantula S, Nammi S, Kolanukonda R, Koppula S, Boini KM. Adaptogenic and nootropic activities of aqueous extract of Vitis vinifera (grape seed): An experimental study in rat model. BMC Complement Altern Med. 2005;5(1):1.
  16. El-Awdan SA, Abdel Jaleel GA, Saleh DO. Grape seed extract attenuates hyperglycaemia-induced in rats by streptozotocin. Bull Fac Pharmacy, Cairo Univ. 2013;51(2):203-9.
  17. Monsefi M, Parvin F, Farzaneh M. Effects of plum extract on skeletal system of fetal and newborn mice. Med Princ Pract. 2013;22(4):351-6.
  18. Mirza MB, Elkady AI, Al-Attar AM, Syed FQ, Mohammed FA, Hakeem KR. Induction of apoptosis and cell cycle arrest by ethyl acetate fraction of Phoenix dactylifera L. (Ajwa dates) in prostate cancer cells. J Ethnopharmacol. 2018;218:35-44.
  19. Hamouda AF, Shaban NZ. Short and long term effects of pomegranate (Punica granatum) extracts on apoptosis in rat kidney induced by diethylnitrosamine and phenobarbital. J Pharm Pharmacol. 2016;4:52-63.
  20. Taha NA, Alkhawajah AAM, Raveesha KK. Acute and subacute toxicity studies of Persea americana Mill (Avocado) seed in rats. Int J Med Toxicol Leg Med. 2008;11(2):31-6.
  21. Khan TJ, Kuerban A, Razvi SS, Mehanna MG, Khan KA, Almulaiky YQ, et al. In-vivo evaluation of hypolipidemic and antioxidative effect of ‘Ajwa’(Phoenix dactylifera L.) date seed-extract in high-fat diet-induced hyperlipidemic rat model. Biomedicine and Pharmacotherapy. 2018;107:675-80.
  22. Egbuonu ACC, Omodamiro OD, Achi NK, Opara CI. Effect of ethanolic extract of avocado pear (persea americana) seed on normal and monosodium glutamate-compromised rats’ kidney histology and serum bio-functional parameters. EC Pharmacol Toxicol. 2017;4(6):271-84.
  23. Abdel-Moneim A, Ahmed OM, Fahim HI, Mohamed EE. The preventive effects of avocado fruit and seed extracts on cardio-nephrotoxicity induced by diethylnitrosamine/2-acetylaminoflurine in wistar rats. Basic Sci Med. 2017;6(1):4-13.
  24. Hamouda AF. A biochemical study of agarwood on methanol injection in rat. Ashdin Publ J Drug Alcohol Res. 2019;8(1):1-14.
  25. Umesh HR, Ramesh KV, Devaraju KS. Molecular docking studies of phytochemicals against trehalose-6-phosphate phosphatases of pathogenic microbes. Beni-Suef Univ J Basic Appl Sci. 2020;9(1):5.
  26. Trott O, Olson AJ. AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455-61.
  27. Tyagi R, Verma S, Mishra S, Srivastava M, Alam S, Khan F, et al. In-vitro and in silico studies of glycyrrhetinic acid derivatives as anti-filarial agents. Curr Top Med Chem. 2019;19(14):1191-200.
  28. Sehnal DR, Rose AS, Koca J, Burley S, Velankar S. Mol*: towards a common library and tools for web molecular graphics. Inworkshop on molecular graphics and visual analysis of molecular Data. The Eurographics Association. 2018.
  29. Harish BM, Devaraju KS, Gopi A, Saraswathi R, Babu RL, Chidananda Sharma S. In silico binding affinity study of calcineurin inhibitors to calcineurin and its close associates. Indian J Biotechnol. 2013;12:213-7.
  30. Sharma A, Batra A. Primary metabolite profiling of tinospora cordifolia. Nat Prod Chem Res. 2016;4(4):1-7.
  31. Wink M. Modes of action of herbal medicines and plant secondary metabolites. Medicines. 2015;2(3):251-86.
  32. Hamouda AF, Sameeh MY, Shrourou RM. Effect of avocado (persea americana), cabbage (brassica oleracea) and ginger (zingiber officinale) on rat liver and thyroid injuries induced by CCl4 (Carbon Tetrachloride). J Pharm Pharmacol. 2016;4:108-18.
  33. Asmaa F Hamouda. Study on the effect of avocado on apoptosis, oxidative stress and injuries induced by diethyl nitrosamine in rat liver. J Pharm Pharmacol. 2015;3(5):243-52.
  34. Asmaa F Hamouda, Nadia Z Shaban. Short and long term effects of pomegranate (punica granatum) extracts on apoptosis in rat kidney induced by diethylnitrosamine and phenobarbital. J Pharm Pharmacol. 2016;4(2):52-63.
  35. Hamouda A, Shaban N, Talaat I. Effects of some pyrimidine derivatives and pomegranate juice on male rat kidney injuries induced by diethylnitrosamine and carbon tetrachloride. Biol Chem Res. 2015;2015:215-29.
  36. Martin ME, Grao-Cruces E, Millan-Linares MC, Montserrat-de la Paz S. Grape (Vitis vinifera L.) seed oil: a functional food from the winemaking industry. Foods. 2020;9(10):1360.
  37. Gorodyska O, Grevtseva N, Samokhvalova O, Gubsky S. Determination of the chemical composition of grape seed powders by gc-ms analysis. Eureka Life Sci. 2018;6(6):3-8.
  38. Felhi S, Baccouch N, Salah HB, Smaoui S, Allouche N, Gharsallah N, Kadri A. Nutritional constituents, phytochemical profiles, in-vitro antioxidant and antimicrobial properties and gas chromatography-mass spectrometry analysis of various solvent extracts from grape seeds (Vitis vinifera L.). Food Sci Biotechnol. 2016;25(6):1537-44.
  39. McKinney MK, Cravatt BF. Structure and function of fatty acid amide hydrolase. Annu Rev Biochem. 2005;74(1):411-32.
  40. Cravatt BF, Prospero-Garcia O, Siuzdak G, Gilula NB, Henriksen SJ, Boger DL, et al. Chemical characterization of a family of brain lipids that induce sleep. Science. 1995;268(5216):1506-9.
  41. Thomas A, Stevenson LA, Wease KN, Price MR, Baillie G, Ross RA, Pertwee RG. Evidence that the plant cannabinoid Δ9‐tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist. Br J Pharmacol. 2005;146(7):917-26.
  42. Pertwee RG, Thomas A, Stevenson LA, Ross RA, Varvel SA, Lichtman AH, et al. The psychoactive plant cannabinoid, Δ9‐tetrahydrocannabinol, is antagonized by Δ8‐and Δ9‐tetrahydrocannabivarin in mice in-vivo. Br J Pharmacol. 2007;150(5):586-94.
  43. Brocks JJ, Jarrett AJM, Sirantoine E, Hallmann C, Hoshino Y, Liyanage T. The rise of algae in Cryogenian oceans and the emergence of animals. Nature. 2017;548(7669):578-81.
  44. Ohara T, Sato T, Shimizu N, Prescher G, Schwind H, Weiberg O, et al. Acrylic acid and derivatives. in: ullmann’s encyclopedia of industrial chemistry. Wiley. 2020;1-21.
  45. Coessens V, Pintauer T, Matyjaszewski K. Functional polymers by atom transfer radical polymerization. Prog Polym Sci. 2001.
  46. Joo SS, Kim YB, Lee DI. Antimicrobial and antioxidant properties of secondary metabolites from white rose flower. Plant Pathol J. 2010;26(1):57-62.
  47. Gad SE, Barbare R. Phosphoric acid. In: Encyclopedia of Toxicology. Elsevier; 2005:414-5.
  48. Markowiak-Kopeć P, Śliżewska K. The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome. Nutrients. 2020;12(4):1107.
  49. McDonald JA, Mullish BH, Pechlivanis A, Liu Z, Brignardello J, Kao D, et al. Inhibiting growth of clostridioides difficile by restoring valerate, produced by the intestinal microbiota. Gastroenterology. 2018;155(5):1495-507.
  50. Hunter JE, Zhang J, Kris-Etherton PM, Childs L. Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated and unsaturated fatty acids: A systematic review. Am J Clin Nutr. 2010;91(1):46-63.
  51. Mortensen A, Aguilar F, Crebelli R, Di Domenico A, Dusemund B, Frutos MJ, et al. Re‐evaluation of fatty acids (E 570) as a food additive. EFSA J. 2017;15(5):4785.
  52. Rodrigues B, Sawant A. Anti-microbial and anti-cancer activity of setosphaeria monoceras, an endophytic fungus associated with tropical mangrove plant. World J Pharm Pharm Sci. 2018;6(6):1315-29.
  53. Sharma D, Pramanik A, Agrawal PK. Evaluation of bioactive secondary metabolites from endophytic fungus pestalotiopsis neglecta BAB-5510 isolated from leaves of cupressus torulosa D. 3-Biotech. 2016;6(2):210.
  54. Devi N, Singh M. GC-MS analysis of metabolites from endophytic fungus collectotrichum gloeosporiodes isolated from phlogacanthus thyrsiflorus. Int J Pharm Sci Rev Res. 2013;23(2):392-5.
  55. Yadav A, Yadav M, Kumar S, Sharma D, Yadav JP. In-vitro antioxidant activities and GC-MS analysis of different solvent extracts of acacia nilotica leaves. Indian J Pharm Sci. 2018;80(5):892-902.
  56. Yoshihara S, Mizutare T, Makishima M, Suzuki N, Fujimoto N, Igarashi K, et al. Potent estrogenic metabolites of bisphenol A and bisphenol B formed by rat liver S9 fraction: Their structures and estrogenic potency. Toxicol Sci. 2004;78(1):50-9.
  57. Okuda K, Takiguchi M, Yoshihara S. In-vivo estrogenic potential of 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene, an active metabolite of bisphenol A, in uterus of ovariectomized rat. Toxicol Lett. 2010;197(1):7-11.
  58. Jasiem TM, Nasser NM, Baderden SK, Hasan HA. Pharmacognostical and phytochemical studies of Iraqi hibiscus rosa-sinensis. In: AIP Conference Proceedings. American Institute of Physics Inc. 2019;2144:1-6.
  59. Huang B, Ban X, He J, Tong J, Tian J, Wang Y. Comparative analysis of essential oil components and antioxidant activity of extracts of Nelumbo nucifera from various areas of China. J Agric Food Chem. 2010;58(1):441-8.
  60. González-García E, Marina ML, García MC. Plum (Prunus Domestica L.) by-product as a new and cheap source of bioactive peptides: Extraction method and peptides characterization. J Funct Foods. 2014;11:428-37.
  61. Savić IM, Nikolić VD, Savić-Gajić IM, Kundaković TD, Stanojković TP, Najman SJ. Chemical composition and biological activity of the plum seed extract. Adv Technol. 2016;5(2):38-45.
  62. Fotschki B, Jurgoński A, Juśkiewicz J, Zduńczyk Z. Metabolic effects of dietary apple seed oil in rats. Zywn Nauk Technol Jakosc. 2015;198:220-31.
  63. Jurgoński A, Juśkiewicz J, Zduńczyk Z. A high-fat diet differentially affects the gut metabolism and blood lipids of rats depending on the type of dietary fat and carbohydrate. Nutrients. 2014;6(2):616-26.
  64. Lunn J, Theobald HE. The health effects of dietary unsaturated fatty acids. Nutr Bull. 2006;31(3):178-224.
  65. Manosso LM, Neis VB, Moretti M, Daufenbach JF, Freitas AE, Colla AR, et al. Antidepressant-like effect of α-tocopherol in a mouse model of depressive-like behavior induced by TNF-α. Prog Neuro-Psychopharmacology Biol Psychiatry. 2013;46:48-57.
  66. Djoussé L, Matthan NR, Lichtenstein AH, Gaziano JM. Red blood cell membrane concentration of cis-palmitoleic and cis-vaccenic acids and risk of coronary heart disease. Am J Cardiol. 2012;110(4):539-44.
  67. Field CJ, Blewett HH, Proctor S, Vine D. Human health benefits of vaccenic acid. Appl Physiol Nutr Metab. 2009;34(5):979-91.
  68. Glennon RA, Young R. Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP). Brain Res Bull. 2016;126(1):111-26.
  69. Abdulmalik O, Safo MK, Chen Q, Yang J, Brugnara C, Ohene‐Frempong K, et al. 5-Hydroxymethyl-2-furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells. Br J Haematol. 2005;128(4):552-61.
  70. Priyadarshi S, Khanum H, Ravi R, Borse BB, Naidu MM. Flavour characterisation and free radical scavenging activity of coriander (Coriandrum sativum L.) foliage. J Food Sci Technol. 2016;53(3):1670-8.
  71. Čechovská L, Cejpek K, Konečný M, Velíšek J. On the role of 2,3-dihydro-3,5-dihydroxy-6-methyl-(4H)-pyran-4-one in antioxidant capacity of prunes. Eur Food Res Technol. 2011;233(3):367-76.
  72. Olowokere JA, Onen AI, Odineze MC, B’aga ID, Kefas EG. Extraction and characterization of oil from date palm (phoenix dactylifera) seed. Asian J Appl Chem Res. 2019;3(4):1-9.
  73. Alqarni MMM, Osman MA, Al-Tamimi DS, Gassem MA, Al‐Khalifa AS, Al‐Juhaimi F, et al. Antioxidant and antihyperlipidemic effects of Ajwa date (Phoenix dactylifera L.) extracts in rats fed a cholesterol-rich diet. J Food Biochem. 2019;43(8):e12933.
  74. Junwei L, Juntao C, Changyu N, Peng W. Molecules and functions of rosewood: Pterocarpus cambodianus. Arab J Chem. 2018;11(6):763-70.
  75. Tabeshpour J, Razavi BM, Hosseinzadeh H. Effects of avocado (persea americana) on metabolic syndrome: a comprehensive systematic review. Phyther Res. 2017;31(6):819-37.
  76. Bahru T, Tadele Z, Ajebe E. A review on avocado seed: functionality, composition, antioxidant and antimicrobial properties. Chem Sci Int J. 2019;27(2):1-10.
  77. Alam EA. Volatile compounds of egyptian fruits of rumex vesicarius l. Int J Pharm Pharm Sci. 2014;6(3):18-9.
  78. Fukuzawa M, Yamaguchi R, Hide I, Chen Z, Hirai Y, Sugimoto A, et al. Possible involvement of long chain fatty acids in the spores of Ganoderma lucidum (Reishi Houshi) to its anti-tumor activity. Biol Pharm Bull. 2008;31(10):1933-7.
  79. Iijima H, Kasai N, Chiku H, Murakami S, Sugawara F, Sakaguchi K, et al. The inhibitory action of long-chain fatty acids on the DNA binding activity of p53. Lipids. 2006;41(6):521-7.
  80. Joo JH, Jetten AM. Molecular mechanisms involved in farnesol-induced apoptosis. Cancer Lett. 2010;287(2):123-35.
  81. Elsayed TR, Galil DF, Sedik MZ, Hassan HMM, Sadik MW. Antimicrobial and anticancer activities of actinomycetes isolated from Egyptian soils. Int J Curr Microbiol Appl Sci. 2020;9(9):1689-700.
  82. Jasiński M, Stukkens Y, Degand H, Purnelle B, Marchand-Brynaert J, Boutry M. A plant plasma membrane ATP binding cassette-type transporter is involved in antifungal terpenoid secretion. Plant Cell. 2001;13(5):1095-1107.
  83. Wang S, Su R, Nie S, Sun M, Zhang J, Wu D, et al. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J Nutr Biochem. 2014;25(4):363-76.
  84. Duncan R, Gaspar R. Nanomedicine(s) under the microscope. Mol Pharm. 2011;8(6):2101-41.
  85. Sarker SD, Nahar L. Application of nanotechnology in phytochemical research. Pharm Sci. 2017;23(3):170-1.
  86. Wei A, Mehtala JG, Patri AK. Challenges and opportunities in the advancement of nanomedicines. J Control Release. 2012;164(2):236-46. 

Asmaa Fathi Hamouda1,2*, Taymour-Lank Mohammed Farawilla3, Ibraheem Mohammed Attafi4, Ibrahim Abdu Khardali4, Mohammad Ahmad Attafi4, Magbool Essa Oraiby4, Farid Mohammad Abualsail4

1Department of Biochemistry, Faculty of Science, University of Alexandria, Alexandria, Egypt
2Assistant Professor Faculty of Applied Health Sciences, Jazan University, Saudi Arabia
3Department of Chemistry, Faculty of Science, University of Alexandria, Alexandria, Egypt
4Poison Control and Medical Forensic Chemistry Center, Ministry of Health, Jazan, Kingdom of Saudi Arabia

*Corresponding Author: Asmaa Fathi Hamouda, Alexandria University, Egypt, Assistant Professor in the Umm Al-Qura University, Saudi Arabia (2014-2016) and Assistant Professor Faculty of Applied Health Sciences, Jazan University, Saudi Arabia, Email: [email protected]

 

Copyright© 2021 by Hamouda AF, et al. All rights reserved. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Citation: Hamouda AF, et al. Screening Pilot Study of Fruit Seed Compositions by GC-MS and Their Potential Scenario Anti ACE2 and 2rh1 Receptors as a Recycling Possibility in the Coronavirus Pandemic. J Clin Med Res. 2021;2(2) :1-65.